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1. Introduction 
 
1.1. Biomedical and environmental applications of polymers 
Polymers represent a versatile platform of materials for applications in the biomedical and 
environmental field. The large availability of chemical structures and functionalities of polymers 
allows for a proper selection of the materials according to the envisaged application. In biomedical 
and environmental fields it is required the use of materials matching stringent criteria such as 
biocompatibility and biodegradability. To this aim polymers of natural origin could represent the 
most suitable materials since they are inherently biocompatible and biodegradable. Their use in 
biomedical applications is especially advantageous since their chemical resemblance to biological 
macromolecules allows for their positive interactions with the biological environment. Indeed 
natural polymers are reported to avoid the stimulation of chronic inflammation or immunological 
reactions and toxicity, often detected with synthetic polymers1,2. The inherent biodegradability of 
natural polymers would pose less concerns regarding their disposal and use in environmental 
applications. Their natural origins allow for the exploitation of renewable and possibly sustainable 
resources thus overcoming the concerns related to the exploitation of petrol chemical resources. The 
main drawbacks encountered with the use of natural polymers are related to their poor mechanical 
and thermal stability especially if compared with those of synthetic polymers. Nevertheless the high 
degree of chemical functionalization typically found in polymers of natural origin allows for their 
modification to provide materials with the tailored properties. Polymers of synthetic origin have 
been mostly used in environmental fields such as food packaging since the criteria that regulate 
these applications are less stringent with respect to those encountered in biomedical fields. 
Biodegradability and biocompatibility are not exclusive properties of natural polymers and can be 
found also in polymers of synthetic origins. Synthetic polymers are mostly obtained by petrol 
chemical resources and their uncontrollable exploitation could lead to unsustainable processes 
detrimental for the environment. Their wide use in environmental applications was justified by their 
mechanical and thermal stability and the higher resistance to moisture provided by their higher 
hydrophobicity in comparison to natural polymers. The lower degree of functionalization typically 
found in synthetic polymers would however limit their versatility and possibility of development. 
The most investigated polymers for biomedical and environmental applications will be described in 
the next paragraphs highlighting their current employments and future perspectives. 
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1.1.1. Natural polymers 
1.1.1.1. Polypeptides 
Natural polypeptides are macromolecules composed by aminoacids linked to each other by amidic 
bond, defined as peptide bond (Figure 1).  
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Figure 1. Chemical structure of a polypeptide. In the small box is evidenced the peptide bond between two 
consecutive  amìnoacids. 
 
Proteins represent the most important class of natural polypeptides. They consist of long chains of 
amino acids connected by peptide bonds between the α-carboxyl and the α-amino functions of 
consecutive units. Since mammalian tissues have represented the main source of these materials 
their use was accompanied by concerning side effects such as disease transmission and 
immunogenic responses in vivo3,4. Peptide synthesis and genetic engineering have represented 
valuable tools to overcome these limitations. Chemical synthesis can be a quick and efficient 
method to fabricate short peptides in relatively small quantities5. However, the synthesis of peptide 
sequences with more than 35–40 amino acids is not feasible due to a drop in yield and efficiency 
accompanied by an exponential increase in cost6. Genetic engineering revealed as an useful tool for 
producing polypeptides with better control in term of peptide sequence in respect to the synthetic 
methods17s. The most important polypeptides currently exploited in biomedical applications will be 
described by focusing on their reported chemical functionalization. 
Collagen is the most abundant protein in the mammalian body, accounting for 20–30% of the total 
protein mass8. Its primary functions in tissues are to provide mechanical support9. Collagens form a 
large family of macromolecules arranged in a triple-helical structure with about 28 different types 
described10. The triple-helical structure of collagen arises from an unusual abundance of three 
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amino acids: glycine, proline, and hydroxyproline. These aminoacids constitute the characteristic 
repeating motif glycyne-proline-X, or glycine-X-hydroxyproline where X can be any amino acid. 
Collagen is easy to modify and process and its abundance, biodegradability and biocompatibility 
make collagen a promising biopolymer for applications in the medical and pharmaceutical fields9. 
Reconstituted gels of type I collagen are widely used for biomedical applications and its main 
sources are animal tissues such as skin and tendons11,12. The main drawback of using collagen from 
animal tissues is given by its immunogenicity and the risks of infectious disease transmission. 
These disadvantages has been partially overcome by biotechnologies such as genetic engineering 
that have been currently involved in the development of human sequence collagen through 
recombinant systems. Collagen scaffolds have been extensively used for soft tissue repair13, 
vascular14 and dermal tissue engineering15,16, bone repair17 and as a carrier for the delivery of 
drugs18 and biologically active molecules19-21. However, despite the wide range of applications 
collagen matrices lack the mechanical properties required for several tissue engineering 
applications. To this aim collagen is currently blended with other materials, either synthetic22 of 
natural23 origin, providing hybrid matrices suitable for the required applications24. 
Gelatin is a denatured protein obtained by acid or alkaline hydrolysis of collagen. Two types of 
gelatin are obtained from collagen, depending on the pre-treatment procedure and are commercially 
available as type-A gelatin (isoelectric point, pH ~ 8-9) and type-B gelatin (isoelectric point, pH ~ 
4-5). Type A gelatin is obtained under acid hydrolysis conditions while Type B gelatin is obtained 
under basic hydrolysis of collagen. Collagen denaturation causes the loss of the triple-helix 
conformation due to destruction of the hydrogen bonds between the chains. The amino acid 
composition of gelatin is very close to that of its parent collagen, and is characterized by a repeating 
sequence of glycine-proline-X or glycine-X-hydroxyproline sequence. The source, age of the 
animal, and type of collagen, are all intrinsic factors influencing the properties of the derived 
gelatins25. The most abundant sources of gelatin are pig skin (46%), bovine hide (29.4%) and pork 
and cattle bones (23.1%)26. Gelatin has been generally used in food, photographic, cosmetic and 
pharmaceutical application mainly because of its gel-forming and viscoelastic properties. Recently, 
an increasing number of new applications for gelatin have been developed in products such as 
emulsifiers, foaming agents, colloid stabilizers, fining agents, biodegradable packaging materials 
and micro-encapsulating agents, in line with the growing trend to replace synthetic materials with 
natural ones26. 
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Fibronectin is also a component of the extracellular matrix with important functions such as 
structural support and signaling for cell survival, migration, contractility, differentiation and growth 
factor signalling27. Fibronectin usually exists as a dimer composed of two nearly identical ∼250 
kDa subunits linked covalently near their C-terminal by a pair of disulfide bonds. Each monomer 
consists of three types of repeating units type I, type II, and type III. Fibronectin contains 12 type I 
repeats, two type II repeats and 15-17 type III repeats, which together account for approximately 
90% of the protein sequence. Type I repeats are about 40 aminoacid residues in length and contain 
two disulfide bonds; type II repeats comprise a stretch of approximately 60 aminoacids and two 
intrachain disulfide bonds; and type III repeats are about 90 residues long without any disulfide 
bonds28. The use of fibronectin or domains of the protein to functionalize scaffolds for tissue 
engineering has been often investigated in virtue of its biocompatibility and ability to bind to 
integrins29. Polymeric scaffolds of chitosan30,31, collagen32 and hyaluronic acid33 have been 
modified with fibronectin to improve cell adhesion and proliferation. Multilayer films of poly-
lysine and dextran sulfate conjugated to fibronectin have been developed as matrices for the study 
of the spreading behavior of human umbilical vein endothelial cells34. The cells showed to spread to 
a great extent on the films coated with fibronectin, thus confirming the positive effect of fibronectin 
in favouring cell interactions with the host materials34. 
Elastin is a protein mainly present in connective and vascular tissues. It is formed by the 
crosslinking reactions of the soluble tropoelastin protein precursors. Elastin fibers are an important 
component of the extracellular matrix whose role is to impart elasticity to organs and tissues. 
Hydrophobic domains present in the elastin sequence are responsible for these elastic properties35,36. 
Elastin displays also chemotactic activity, inducing cell proliferation and regulating cell 
differentiation through the specific binding of integrin αvβ3 to the C-terminus of tropoelastin37. Due 
to its characteristics elastin has been of interest for drug delivery and tissue engineering and has 
been used in the fabrication of hybrid materials in combinations with collagen38, polycaprolactone 
(PCL)39 and silk40 for the production of vascular grafts41, hydrogels42, bone repair43 and for drug 
delivery44. Artificial proteins incorporating elastin-like peptides have been of interest for the 
development of new protein-based biomaterials45,46 with properties similar to native elastin47. 
Fibrin is another example of a extracellular matrix protein having displayed potential application 
for tissue engineering. Fibrin is the result of fibrinogen polymerization in the presence of 
thrombin48. Fibrinogen is a 340 kDa protein present in plasma formed by pairs of three different 
polypeptides, Aα, Bβ and γ, held together by disulfide bridges49. Fibrin is used clinically as a 
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medical adhesive and it is approved by FDA as sealant. Fibrin is also used for skin repair, replacing 
sutures and staples in fixation of skin grafts promoting a better wound healing50, and in the 
transplantation of keratinocytes in burned patients12. This protein revealed also as promising 
material for applications in tissue engineering in the repair of damaged tissues51,52, and drug 
delivery, as a carrier for growth factors53. 
Silk is another example of a hierarchically structured fibrous protein. It is characterized by 
outstanding mechanical properties matching those of high performance man made fibers such as 
kevlar and nylon54. Silks are generally composed by β-sheet structures due to the dominance of 
hydrophobic domains consisting of short side chain amino acids in the primary sequence. Large 
hydrophobic domains interspaced with smaller hydrophilic domains are reported to induce the 
typical assembly of silk and the strength and resiliency of silk fibers55. Silk-protein-based fibers are 
produced by insects56 and spiders57 in the productions of cocoon, traps, web formation, nest 
building, safety lines and egg protection58,59. Silk produced by the species Bombyx mori is the most 
well studied silk protein56. The silk fiber is formed by two microfilaments embedded in glue-like 
glycoproteins named sericin, which works as a coating. Each microfilament results from the 
assembly of a hydrophobic ~370 kDa heavy-chain fibroin protein, a relatively hydrophilic ~25 kDa 
light-chain fibroin and a 30 kDa P25 protein60. The outstanding mechanical features and 
biocompatibility are reasons why silk has been used through the millennia in such diverse 
applications as fabrication of paper, wound dressing, textiles and sutures61. With new technologies 
in the fields of polymer synthesis and processing, silk continues to be an important topic of research 
for biomaterial and biomedical research. In the case of B. mori silk, sericulture provides the product 
used by the textile industry and in medical sutures62. Additionally, this silk is being studied for 
tissue engineering in the form of scaffolds for a range of tissue needs, such as corneal 
regeneration63,64, cartilage repair65,66, vascular grafts67,68, bone regeneration69,70 and drug 
delivery71,72. With the advance of biotechnology tools it is now possible to bioengineer spider silk 
genes to produce spider silk-like proteins73, such as for tissue engineering74, cell culture75, nerve 
regeneration76,77 and wound dressings78. The protein-based materials developed for biomedical 
applications have been commonly combined with bioactive molecules in order to increase their 
biocompatibility and favor cell living process. The bioactive agents are conventionally linked to the 
protein-based materials by physical adsorption or covalent conjugation. Physical adsorption is a 
simple immobilization procedure that is frequently used to link bioactive molecules such as 
extracellular matrix proteins or growth factors to the surface of the treated materials79. Adsorption 
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efficiency is dependent on the physical and chemical properties of the material, including 
wettability, surface topography, functional groups, pH and electrical charge, among other factors80. 
Collagen and silk are examples of protein-based materials that have been functionalized through 
adsorption of bioactive molecules, including bone morphogenetic proteins (BMPs)81,82, basic 
fibroblast growth factor (bFGF)83, vascular endothelial growth factor (VEGF)84 and therapeutic 
compounds such as antibiotics85 and heparin86. The binding stability of the adsorbed molecules is 
relatively poor since it is based on relatively weak van der Waals, hydrogen bonds and hydrophobic 
forces. To overcome these issues, covalent immobilization has been widely used since it has the 
advantage of providing stable attachment of bioactive agents to the polymeric scaffolds. With 
proper design, covalent conjugation has proven to be a very effective strategy to control the release 
profile of the immobilized agent since these molecules are retained for longer time periods at the 
delivery site, when compared with adsorption87. Carbodiimide coupling is broadly used in protein 
chemistry to activate the carboxylic acid groups of the protein-based materials towards the reaction 
with the amine groups of the active agent that has to be immobilized88,89. 1-ethyl-3-(3-
dimethylaminopropyl)-carbodiimide (EDC), dicyclohexyl-carboiimide (DCC) and carbonyl 
diimidazole (CDI) represent the chemical agents most used for carboxyl group activation88,89. 
Glutaraldehyde, polyethylene glycol diacrylate and hexamethylene diisocyanate have been also 
used to bridge the amine groups present in the bioactive agent to be immobilized and the protein 
based scaffolds89,90. Glutaraldehyde has been used to couple insulin91 and lipase92 onto silk 
scaffolds and to crosslink blends of collagen and silk93. However, the potential release of toxic 
residual molecules formed during the crosslinking process is a concern if these biomaterials have to 
be used for biomedical applications90.  
Poly-γ-glutamic acid Amide linkages in proteins are formed by the α-amino and α-carboxylic 
groups of consecutive aminoacids (α-amide linkages). Other naturally produced polypeptides are 
known to involve the amino and carboxyl group in the amide bonds in a different reciprocal 
position94. Among them poly-γ-glutamic acid (γ-PGA) is one of the most important. γ-PGA is an 
anionic, water-soluble biodegradable, biocompatible and edible polypeptide produced by microbial 
fermentation (Figure 2). 
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Figure 2. Chemical structure of γ-PGA. 
 
γ-PGA consists of repeating glutamic acid units linked to each other by amide bonds between the α-
amino and γ-carboxylic acid functional groups of two consecutive aminoacids. This biodegradable 
polymer was first isolated in 1937 by autoclaving capsules of Bacillus anthracis95. Later, it was 
discovered that several other Bacillus species were capable of secreting the polymer into culture 
growth medium as well as nematocysts of the eukaryotic organism Hydra (Hydrozoa, 
Cnidaria)96,97. B. licheniformis98 and B. subtilis99,100 have been majorly used for fermentative 
production of γ-PGA. The naturally produced polymers are characterized by molecular weight up to 
1 million containing nearly equal amounts of D- and L-units101. The ratio of the two optical isomers 
can be partially regulated through modern biotechnologies. Indeed the production of γ-PGA 
displaying variable degree of stereoregularity has been yet reported102. In virtue of its 
biodegradability and biocompatibility γ-PGA has been demonstrated a valid material for various 
applications such as drug delivery103,104, tissue engineering105, cosmetics106 and food 
industries107,108. In food industry γ-PGA has been employed for prevention of aging of starch-based 
bakery products, and as an ice cream stabilizer109. A great advantage of this material is given by its 
chemical versatility provided by the large number of pendant carboxyl groups along its backbone 
chain. Indeed this polypeptide could be properly modified by the conventional coupling reactions 
involving carboxyl groups according to the desired applications of the final product. 
 
1.1.1.2. Polysaccharides 
Polysaccharides are complex macromolecules constituted by chains of repeating monosaccharides 
joined together by glycosidic bonds. Differences in the monosaccharide composition, configuration 
of glycosidic bond and molecular weight dictate their physical properties, including solubility, 
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rheological behavior and gelling aptitude. Polysaccharides are widely distributed in nature in plants, 
animals and micro-organisms. They represent valid materials for applications in the biomedical 
field mainly due to their widely ascertained biocompatibility and high chemical versatility given by 
the huge number of functional groups present in their structural units. Indeed, this last feature 
allows for a wide plethora of post-modification reactions to provide the material with the properties 
required for the envisaged applications. Such advantage cannot be found in any other polymeric 
material either natural or synthetic. Most techniques of conjugations onto polysaccharides are based 
on the reactivity of amine groups and the hydroxyl group of the materials. Chitosan represent the 
most easily modified and tailorable polysaccharide due to the higher reactivity of the amine groups 
respect to hydroxyl and carboxyl group. Amidation reactions mediated by carbodiimides is one of 
the most widely used methods for the modification of amine and carboxyl containing 
polysaccharides110,111. 1-ethyl-3-[3-(dimethylamino)-propyl]-carbodiimide (EDC) is the 
predominantly used carbodiimide due to its water solubility. The hydroxyl groups of 
polysaccharides are commonly involved in esterification reactions. The presence of carboxyl groups 
in the polysaccharide chain such as in the case of hyaluronic acid may be used to link active agents 
to the polymer through amidic or ester bonds112. Another useful method to modify polysaccharides 
is by ring opening polymerization (ROP) of cyclic monomer such as lactones and lactides by using 
the hydroxyl groups of the polymer as initiator113. Tin(II) 2-ethylhexanoate (Sn(Oct)2) has been 
commonly used as catalyst in this type of conjugation for the polymerization of monomers such as ε 
-caprolatone (ε -CL), lactide (LA) and p-dioxanone114. A description of the polysaccharides most 
exploited in biomedical and environmental applications will be given in this section by outlining 
their chemical modifications and pratical applications 
Starch (Figure 3) is a mixture of glycans that plants synthesize as their principal food reserve. It is 
deposited in the chloroplasts of plant cells as insoluble granules composed of α-amylose (normally 
20–30%) and amylopectin (normally 70–80%)115. α-Amylose is a linear polymer composed by 
several thousands of glucose residues linked by α(1→4) bonds. Amylopectin, consisting mainly of  
α(1→4)-linked glucose residues with α(1→6) branching points at every 24–30 glucose residues. 
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Figure 3. Chemical structure of starch: a) amylopectin, b) amylose 
 
Starch has been extensively exploited as a carrier for drug delivery due to its biodegradability and 
long tradition as an excipient in drug formulations116. Micro- and nanoformulations based on starch 
alone117-125, or blended with biodegradable polymeric materials such as poly(ε-polycaprolactone) 
(PCL)126 or pectin127, are widely reported by the literature, and the applications range from delivery 
of drugs such as dexamethasone126, diclofenac sodium117, flufenamic acid121, doxorubicin123 and 
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folate124, to growth factors125, proteins122 and cells119. Starch obtained from waste or non-edible 
resources could yet represent a valuable resource of biomaterials. Indeed, new and economically 
advantageous resources of non-edible starch, such as wasted and spoiled grain, are currently 
exploited for the preparation of biobased plastics128. 
Cellulose (Figure 4) is the primary structural component of plant cell walls. It is a linear 
polysaccharide constituted by D-glucose units linked by β(1→4) glycosidic bonds. The fully 
equatorial conformation of β-linked glucose residues stabilizes their chair conformation thus 
minimizing the flexibility of the cellulose chains. The rigid conformation of the cellulose chains 
allows for their close packing in parallel structures strengthened by the occurring of many hydrogen 
bondings between the chain. This highly cohesive, hydrogen-bonded structure gives cellulose fibres 
the exceptional strength and makes them water insoluble despite their hydrophilicity129. Cellulosic 
materials exhibit, however, poor degradation in vivo130. Cellulose can also be produced by the 
bacterium Gluconacetobacter xylinus. Bacterial cellulose (BC) has unique properties, including 
biocompatibility, high water-holding capacity, high crystallinity, a fine fibre network and high 
tensile strength in the wet state. In addition to its cost-efficient and relatively simple production, it 
has the advantage of in situ mouldability131.  
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Figure 4. Chemical structure of cellulose. 
 
Since it has good biocompatibility, BC has been investigated for different biomedical applications, 
including wound healing132 and engineering of various tissues, such as blood vessels133, corneas134, 
cartilage135 and bone136,137. The most promising results were obtained by using BC membranes in 
wound dressing, and as composite materials in tissue engineering for inducing bone regeneration. 
Indeed, the gelatinous BC membranes (containing up to 99% of water) obtained directly from 
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bacterial culture, other than displaying the aforementioned unique properties, mostly provided by 
their nanometric 3D structure, proved to be very effective as a barrier against microorganisms in 
wounds and burns, accelerating the healing process, providing pain relief and reducing scar 
formation138-140. 
Chitin (Figure 5a) is the principal structural component of the exoskeletons of invertebrates, such as 
crustaceans and insects, and is also present in the cell walls of most fungi and algae. It is a 
homopolymer of β(1→4)-linked N-acetyl-Dglucosamine residues (GlcNAc)141. Chitin can be 
converted into water soluble derivatives such as chitosan, carboxymethyl chitin and glycochitin, 
among the others142. Chitosan (Figure 5b) is derived from deacetylation of chitin, and it is soluble 
in diluted acids. When chitin is deacetylated to a certain degree (~ 60% deacetylation) it is referred 
to as chitosan. Chitin derivatives possess many unique properties, such as biocompatibility, 
biodegradability, hydrophilicity, adsorption capability and high reactivity. Moreover, chitin-based 
polymers are materials with great versatility to be processed in different forms (fibres, sponges, 
membranes, beads and hydrogels)143,144. 
 
a) 
OHO
NH
OH
C O
H3C
OHO
NH
OH
C O
H3C
OHO
NH
OH
C O
H3C  
Chitin 
b) 
OHO
NH
OH
C O
H3C
OHO
NH2
OH
OHO
NH2
OH
 
Chitosan 
Figure 5. Chemical structure of a) chitin and b) chitosan. 
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Chitosan is widely reported to be highly biocompatible and to display low immunogenicity when 
interfaced with living organisms145-149. In virtue of its biocompatibility and biodegradability, 
chitosan was extensively used in developing drug delivery systems150-155. Different techniques have 
been employed for the preparation of micro- and nanoformulations according to the needs of the 
envisaged applications156. In particular, chitosan particulate systems have been successfully 
prepared by emulsion crosslinking for intranasal systemic delivery of pentazocine157, by 
coacervation/precipitation for gene delivery158, by spray-drying for delivery of betamethasone 
disodium phosphate159, by ionic gelation160, by reverse micellar method for tumor targeted delivery 
of encapsulated dextran-doxorubicin conjugates161 and by sieving method for the controlled release 
of clozapine162. 
Hyaluronic acid (Figure 6), also known as hyaluronan or hyaluronate, is an important 
glycosaminoglycan component of connective tissue, synovial fluid (the fluid that lubricates joints) 
and the vitreous humour of the eye163. Its chemical structure is characterized by the repetition of the 
disaccharidic unit composed by D-glucuronic acid and d-N-acetylglucosamine linked together 
through alternating β-1,4 and β-1,3 glycosidic bonds. Hyaluronic acid can be easily and controllably 
produced in large scales through microbial fermentation, enabling the scale-up of derived products 
and avoiding the risk of animal-derived pathogens. 
 
O O
O
HO
OH
HOOC
O
HO
OH
NH
CO
CH3  
Figure 6. Chemical structure of hyaluronic acid. 
 
It has been widely used for drug delivery applications due to its various biological functions, 
desirable physicochemical properties, biocompatibility, biodegradability and non-
immunogenicity164. HA has been experimentally studied as a potential agent of therapeutic 
intervention in osteoarthrosis165.169. Since hyaluronic acid is highly hydrophilic, it is a polymer that 
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is well suited to applications requiring minimal cellular adhesion. Postoperative adhesions, which 
form between adjacent tissue layers following surgery, impede wound healing and often require 
additional surgical procedures to be repaired successfully. Barriers made from cross-linked 
hyaluronic acid have been effectively used to prevent such adhesions from forming170. 
Algal Polysaccharides Algae undoubtedly represent an ideal renewable resource of biomaterials 
since they are very abundant and cheap, not interfering with the food chain and are often involved 
in detrimental processes to the environment171. Indeed, their natural uncontrolled proliferation is 
responsible for the death of marine and aquatic organisms, and most of this huge biomass is left to 
decompose on the shore creating waste problems172. A growing interest is upsurging to exploit 
algae as a valid resource of materials thus reducing their negative impact to the environment and the 
concerns relevant to their disposal. Polysaccharides have been demonstrated the most useful 
materials obtainable from algae biomass due to their abundance and peculiar chemical composition 
not found in any other organisms. They match perfectly the basic requirement of biocompatibility 
that materials should have to be interfaced with living organisms. Indeed, they do not require the 
accurate purification steps necessary for the exploitation of polysaccharides of animal origins due to 
their lower risks of immunogenicity and disease transmission173. Two different types of algal 
polysaccharides will be described in this section namely alginate and ulvan in virtue of their 
respectively extensive applications and peculiar chemical structure. 
Alginate (Figure 7) represents the most investigated polysaccharide material of algal origin due to 
its biocompatibility, low toxicity and relatively low cost174. Commercial alginates are extracted 
primarily from three species of brown algae (i.e. Laminaria hyperborea, Ascophyllum nodosum and 
Macrocystis pyrifera), in which alginate comprises up to 40% of the dry weight175. Alginates are 
constituted of varying amounts of (1-4)-linked β−D-mannuronic acid and a-L-guluronic acid, whose 
composition and sequence is variable along the polymer chain. The proportions of mannuronic and 
guluronic residues, and the lengths of the blocks, can vary considerably, depending on the source of 
the alginate. The polymer undergoes ionotropic gelation in the presence of divalent cations and 
gelling depends on the ion binding (Mg2+ << Ca2+ < Sr2+ < Ba2+)176. One of the drawbacks of 
alginate hydrogels is that the degradation occurs via a slow and unpredictable dissolution process in 
vivo177. 
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Figure 7. Chemical structure of alginate. 
 
Alginate gels have been widely explored over the past decades as vehicles for delivering proteins or 
cell that can direct the regeneration or engineering of various tissues and organs in the body. The 
various applications depended upon the gelling approach that ultimately defines the physical and 
biodegradation properties of the final materials. Indeed, the release of most proteins and cells would 
need the degradation of the supporting gel due to the unsuitable pore diameters of the original 
matrix178,179. Several strategies have been successfully investigated using alginate hydrogels for 
bone regeneration, such as the delivery of suitable growth factors either in combinations180,181 or 
sequentially182 for cell transplantation, especially using arginine-glycine aspartic acid (RGD)-
containing matrices183,184 and hybrid materials containing inorganic calcium compounds, such as 
calcium hydroxyapatites, to enhance bone tissue formation185,186. However, the low stiffness and 
inherent in vivo dissolution of alginate gels are representative of the severe limitations that might 
hamper their use for bone regeneration. Alginate hydrogels had particularly promising results in the 
encapsulation of hepatocytes for the development of a bioartificial liver187-190, and in the 
encapsulation and transplantation of encapsulated pancreatic islet allografts and xenografts for the 
treatment of diabetes type I in animal models191,192. 
Ulvans (Figure 8) are extracted from the cell walls of marine green algae belonging to Ulva 
species193 They are characterized by a heterogeneous chemical composition, which varies 
depending on several factors including the taxonomic and ecophysiological origins of the algal 
sources194 They are mainly composed of a disaccharide repeating unit containing an uronic acid 
such as D-glucuronic or D-iduronic acid, linked to L-rhamnose-3-sulfate. These polysaccharides are 
supposed to be not toxic toward interfaced organisms since are widely reported to display a wide 
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range of biological activities including antiviral195, anticoagulant196, antioxidant197 and 
antihyperlipemic198 properties. 
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Figure 8. Chemical structure of ulvans. Most representative repeating units. 
 
To date this material is still underexploited and only few paper have reported its use in biomedical 
applications199. However its peculiar chemical structure resembling that of glycosaminoglycan such 
as chondroitin sulfate would provide the material with the desired properties to be successfully 
employed in biomedical applications. Furthermore the exploitation of this algal biomass would 
undoubtedly represents a valuable example of sustainable process for the conversion of renewable 
and abundant waste material to high added-value applications200-202. 
 
1.1.1.3. Polyhydroxyalkanoates 
Polyhydoxyalkanoates (PHAs) are polyesters produced by certain classes of microorganisms under 
unbalanced growth conditions203. Many species of bacteria, which are members of the family 
Halobactericeae of the Archaea, synthesize PHAs. The list of such microorganisms is growing and 
currently contains more than 300 species204-210. PHAs of different structures have been isolated but 
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to date poly(3-hydroxybutyrate) (PHB) represent the most investigated and widely produced 
polymer211,212. The chemical structures of the most representative PHAs are reported in Figure 9. 
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n = 1 R = methyl Poly(3-hydroxybutyrate)  (PHB) 
       ethyl Poly(3-hydroxyvalerate)  (PHV) 
       propyl Poly(3-hydroxyhexanoate) (PHH) 
       pentyl Poly(3-hydroxyoctanoate)  (PHO)  
       eptyl Poly(3-hydroxydecanoate) (PHD) 
n = 2 R = H  Poly(4-hydroxybutyrate)  (P4HB) 
 
Figure 9. Most representative polyhydroxyalkanoates. 
PHAs are attractive material for biomedical applications since they are biodegradable and 
biocompatible. To date PHAs have been used to develop devices including sutures, rivets, bone 
plates, cardiovascular patches, tissue regeneration devices213-215. Monomer composition of the 
produced PHAs depends on the microorganism sources and the growing conditions204,216. For 
example, addition of propionic acid or valeric acid in glucose containing media leads to the 
production of a random copolymer composed of HB and HV [P(HB–HV)]217. The most commonly 
produced PHAs contain a pendant aliphatic chain at C-3 whose length can vary from one carbon to 
over 14 carbon atoms. PHAs can be subdivided into two broad classes according to the length of the 
constituting (co)monomers. PHAs constituted by monomers containing 3-5 carbon atoms are 
classified as short-chain-length (scl-PHAs) whereas medium-chain-length PHAs (mcl-PHAs) 
contain monomers of 6-14 carbon atoms. scl-PHAs have properties close to conventional plastics 
while the mcl-PHAs are regarded as elastomers and rubbers. The conjugation of active molecules or 
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macromolecules to PHAs cannot be easily obtained due to the lack of functional groups. The 
strategy mostly adopted to overcome this drawback and improve the properties of the envisaged 
PHA, rely on the polymerization of monomers suitably functionalized with reactive groups. To this 
aim a few paper reported the preparation of functionalized PHAs by polymerization of monomers 
containing insatured and halogenated lateral chain204,218. Most PHAs produced by microorganisms 
have been found to contain different type of comonomers whose nature was depending on the 
growing conditions. Microorganisms have been reported to synthesize a wide range of PHAs and 
approximately 150 different PHAs have been identified219. Due to their biodegradability, 
biocompatibility and tunable mechanical properties, PHAs such as PHB and PHBV, have been 
investigated for biomedical applications. PHB has found interest as temporary stent, bone plate, 
patch, nails and screws220,221, besides being widely investigated for drug release and tissue 
engineering applications222-224. PHB and PHBV were proposed in the form of matrix for localized 
delivery of antibiotics225-227 and anticancer drugs228. Retinoic acid-loaded PHB nanoparticles were 
recently developed showing good cytocompatibility and prolonged release of the loaded agent229. 
Moreover, PHB and PHBHHX nanoparticles loaded with antineoplastic agents were conjugated 
with tumor-specific ligands for targeted delivery to cancer cells230,231. 
 
1.1.2. Synthetic polymers 
1.1.2.1. Polyesters 
Polyesters represent a class of polymers constituted by the repetition of monomeric units linked to 
each other by ester bonds. They can be prepared according to three different processes: 1) 
polycondensation of hydroxy-acids or of mixtures of diacids and diols, 2) transesterification of 
hydroxyl-esters  and 3) ring-opening polymerization (ROP) of cyclic esters (Scheme 1).  
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Scheme 1. Synthesis of polyesters by a) polycondensation of diacids and diols; b) polycondensation of hydroxy-acids; 
c) transesterification of hydroxyl-esters; d) ring opening polymerization (ROP).   
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The processes of polycondensation (Scheme 1 a-b) usually requires high temperatures and long 
reaction times to be accomplished thus favoring the occurring of side reactions. The 
polycondensation between diacids and diols rarely leads to the formation of polymers with high 
molecular weights due to the concerns related to the hardly matched stoichiometry of the reactants. 
The presence of water is deleterious to the conversion and reproducibility of the process and must 
be avoided. Removal of water is usually accomplished by azeotropic distillation with orgnic 
solvents whose large use on industrial scale and subsequent disposal would pose serious 
environmental concerns. The preparation of polyesters through ROP of the respective cyclic esters 
is free of these limitations and is thus preferred for their synthesis. High molecular weight 
polyesters can be easily prepared under mild conditions from lactones of different ring-size, 
substituted or not by functional groups232,233. In most conditions, the ring-opening polymerization of 
lactones and lactides is a living/controlled process that leads to the preparation of polyesters with 
narrow molecular weight distribution and a mean number molecular weight predetermined by the 
monomer-to-initiator molar ratio. A broad range of salts or organometallic derivatives have been 
reported as catalysts for the synthesis of polyesters234-237. However the residual presence of metallic 
catalysts in the polymers can pose many concerns upon their use in biomedical and environmental 
applications. To this aim the use of enzymes as safer catalysts proved to be a promising strategy for 
the preparation of ”greener” polyesters. Enzymatic catalysts possess many advantages including 
increased catalytic activity, mild reaction conditions, high enantio-, chemo- and regioselectivity, 
and minor formation of by-products (a clean process)238. Indeed enzymatic polymerizations has 
been regarded as an environment-friendly synthetic process and a good example of “eco-friendly” 
polymer synthesis239-245. Among the polyesters used in biomedical and environmental applications 
the most representative are poly(lactic acid) (PLA), poly(glycolic acid) (PGA) and poly(ε-
caprolactone) (PCL) (Figure 10). 
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Figure 10. Chemical structure of PGA, PLA and PCL. 
 
These polyesters are known to be biocompatible and biodegradable. They have found application in 
several fields such as drug-delivery systems, scaffolds for tissue engineered skin and cartilage246,247, 
orthopedic and dental applications246-250. Due to its performing mechanical properties, PLLA has 
been widely investigated for load-bearing applications leading to a wide range of biodegradable 
products such as long-lasting sutures, as well as orthopedic fixation screws, suture anchors, 
meniscal darts and suture reinforcements251. Several papers reported the use of PLA in the 
development of scaffolds for tissue engineering and different strategies have been investigated to 
enhance its bioactivity252-257. Among them Wei et al.258 demonstrated that in vivo release of bone 
morphogenetic protein 7 (BMP-7) from PLGA nanospheres immobilized onto PLLA scaffolds 
induced significant ectopic bone formation through the tissue-engineered construct. PCL is a 
semicrystalline polyester and that can be easily obtained by the ROP of ε-caprolactone, a relatively 
cheap monomer. It is easily processable as it is soluble in a wide range of organic solvents, has a 
low melting point (55–60 °C) and has the ability to form miscible blends with a wide range of 
polymers. This polyester undergoes hydrolytic degradation due to its content of labile aliphatic ester 
linkages in the backbone chain; however, the rate of degradation is usually low (2–3 years). 
The biocompatibility and affinity of PCL towards hydrophobic drugs allowed for its successful use 
in drug delivery259. Lemmouchi et al. investigated the in vitro and in vivo release of selected drugs, 
such as isometamidium chloride and ethidium bromide from poly-ε-caprolactone-co-poly-L-lactide 
based rods and results revealed that the release of isometamidium chloride was faster than for 
ethidium bromide260. PCL scaffolds may have considerable potential for tissue engineering 
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applications due to the enhanced compatibility between this polymer and living organisms. The 
slow degradation rates of PCL have limited its use in tissue engineering but the possibility to easily 
form compatible blends or to prepare copolymers with a wide range of other polymers allowed PCL 
to expand greatly its field of applications261. 
 
1.1.2.2. Polyethers 
Polyethers are polymers that contain the repetition of monomeric units linked to each other by ether 
bonds. Their synthesis is generally performed by anionic ring-opening polymerization (AROP) of 
epoxides (Scheme 2). Epoxide derivatives constitute an interesting and rich family of monomers 
that are readily prepared by the epoxidation of the respective olefins. 
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Scheme 2. Anionic ring-opening polymerization (AROP) of epoxides. I = initiator. 
 
Functionalized polyethers can be easily obtained through AROP of the properly substituted epoxide 
monomers262,263. Alkali metal derivatives like hydrides, alkyls, aryls, amides, and mainly alkoxides 
of sodium, potassium, and cesium, represent the most common initiators used for this kind of 
polymerization264,265. The use of organic initiators and catalysts is nowadays preferred to the 
conventional metallic-based compounds to limit the environmental concerns of the derived 
materials. Although safer this approach still suffers from some limitations. For example the use of 
tertiary amines as initiator in the anionic polymerization of aromatic epoxides led to poor results in 
terms of molar masses and polymerization rates266. N-heterocylic carbenes (NHCs) have been also 
employed to trigger the ROP of some epoxides267-269. Taton et al. showed that 1,3-bis-
(diisopropyl)imidazole-2-ylidene was able to initiate EO polymerization according to a zwitterionic 
mechanism267. Polymerizations were performed at 50 °C in DMSO and required long times to be 
accomplished, i.e., several days. Molar masses up to 13,000 g/mol were obtained with narrow 
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distribution and good agreement between theoretical and experimental values. This approach was 
less effective for the polymerization of propylene oxide due probably to transfer reactions. 
Poly(ethylene oxide) (PEO) and poly(propylene oxide) (PPO) (often referred to as poly(ethylene 
glycol) (PEG) and poly(propylene glycol) (PPG) respectively) represent the most investigated 
polyethers.  They are produced worldwide in several million tons per year in commodity or high 
performance applications270. These polymers are mainly used as surfactants and lubricants, but also 
in biomedical and cosmetic fields271-275. PEG is commonly used in the development of biomedical 
materials because of its unique physicochemical characteristics such as high water solubility, high 
flexibility, and large exclusion volume that provide the final products with improved “stealthing”  
properties276-278. A large variety of copolymers containing polyethers have been studied. Among 
them PEG-poly(b-benzyl-L-aspartate) (PBLA)279, PEG-poly(lactic acid) (PLA)280,281, and PEG-
PCL282,283 have been widely used for drug delivery. Pluronics® (Figure 11), are amphiphilic 
copolymer composed by block of PEG and PPO whose hydrophylicity/hydrophobicity ratios can be 
varied by changing the lengths of the blocks of the constituting units. Pluronics block copolymers 
have been widely used as drug delivery vehicles in virtue of their marked amphiphilicity284-286. 
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Figure 11. Chemical structure of Pluronics®. 
 
1.1.2.3. Polyurethanes 
Polyurethane (PU) represent a class copolymers characterized  by the repetition of aromatic or 
aliphatic units along the backbone chain linked to each other by urethane groups (−NHCOO−) 
(Figure 12).  
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Figure 12. Chemical structure of polyurethanes. 
 
Their preparations require the presence of two essential components: a diisocyanate containing 
compound and a bi- or multi-functional polyol287. The mechanism of polymerization is based on a 
step-growth process involving the formation of urethane bonds between the isocyanate and the 
hydroxyl groups of the envisaged reactants (Scheme 3)288. 
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Scheme 3. Synthesis of polyurethanes. 
 
Dyfferent types of catalysts have been used for the synthesis of polyurethanes. Tertiary amines289, 
such as 1,4-diazabicyclo [2.2.2] octane (DABCO) and triethyl amine (TEA) have been commonly 
employed. Tetravalent tin compounds of the type RnSnX(4-n) with R being a hydrocarbon group 
(alkyl, aryl, cycloalkyl, etc.) represent to date the most efficient catalysts used in this type of 
polymerization290. The preparation of thermoplastic and thermosetting PUs have been both widely 
reported. Thermoplastic PUs are easily obtainable through the polymerization of a diisocyanate 
with a diol species whereas the use of multifunctional components (e.g., triisocyanate or a 
multihydroxyl polyol) would yield thermosetting PUs. The direct reaction of diisocyanate with a 
single long-chain diol group usually produces a soft polymer with low mechanical strength. This 
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property can be drastically changed by the addition of a so-called chain extender, which is usually a 
diol or a diamine287,291-293. The chain extender is typically a shorter chain with lower molecular 
weight in comparison to long chain diols. The extenders and the urethanic group tends to increase 
mechanical strength of these polymers whereas diol chains tends to give soft and elastic properties 
on PUs. Hence, PUs are typically synthesized from three reactant precursors: long-chain polyols 
(usually diols or triols), di- or tri-isocyanates, and chain extenders. The properties of the obtained 
polyurethane produced are primarily dependent on the chemical nature of these three building 
blocks, and their relative proportions in the final polymer293. The biocompatibility of different PUs 
has been investigated both in vitro and in vivo for a wide range of applications, from durable 
medical devices (such as vascular catheters and small diameter vascular grafts for bypass 
surgery)294,295 to biodegradable implants used in tissue engineering296.  
 
1.1.2.4. Polycarbonates 
Polycarbonates are polymers containing carbonate groups in their backbone chain acting as linker 
for the repeating units (Figure 13). 
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Figure 13. General structure of polycarbonates. 
 
Polycarbonates can be divided in two main categories according to the aliphatic or aromatic nature 
of the constituting monomers. Aromatic polycarbonates have been widely used as materials for 
engineering plastics297,298 but in the last decade aliphatic polycarbonates have attracted more 
attention in virtue of their improved biocompatibility, low toxicity, and good biodegradability299,300.  
High molecular weight aliphatic polycarbonates are commonly prepared through ring opening 
polymerization (ROP) of the relevant cyclic compounds301. The most commonly used cyclic 
carbonates for ROP are the five- and six-membered members (Scheme 4). 
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Scheme 4. Synthesis of polycarbonate by ROP. 
 
The preparation of polycarbonates has been usually accomplished by using metallic compounds 
(Sn, Zn, Co, Cr) as catalysts302-304. Metal-free enzymatic polymerization has recently attracted 
interest as a new approach for the preparation of functional polycarbonates due to prominent 
advantages involving nontoxicity, high catalytic efficiency and tolerance towards functional groups 
exerted by enzymes305-310. Polycarbonates containing functionalizable groups (OH, NH2, COOH, 
etc.) in their lateral chains can be easily prepared by ROP of the monomer yet containing the 
envisaged functionality. The introduction of these functional groups are envisaged to allow the 
conjugation of the polymer to bioactive molecules such as drugs and short peptides. 
 
1.1.2.5. Poly-α-(amino acids) 
Poly-α-(amino acids) represent an important class of synthetic polymers whose biocompatibility 
and biodegradability prompted scientists to investigate their feasibility in biomedical 
applications311. Poly-α-(amino acids) can be generally prepared by ROP of the relevant N-carboxy-
anhydrides (NCA) (Scheme 5). 
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Scheme 5. Synthesis of poly-α-(amino acids) by ROP of  the relevant N-carboxy-anhydride. 
 
Poly-α-(L-glutamic acid) (PLGA) and poly(L-lysine) (PLL) represent to date the most investigated 
poly-α-(aminoacids) (Figure 14). PLGA is constituted by the repetition of naturally occurring L-
glutamic acid residues in the backbone chain. Different strategies have been approached to 
functionalize PLGA with bioactive molecules and/or macromolecules. The envisaged modifications 
could be introduced by functionalizing the monomer before its polymerization or by making them 
directly onto the pendant carboxyl groups of the polymer. A further approach could be represented 
by the ring opening copolymerization of the envisaged monomer with a different comonomer 
containing the desired chemical functionality. Most of the designed functionalizations of PLGA 
involved the esterification or amidation of its pendant carboxyl groups through conventional 
coupling reactions. 
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Figure 14. Chemical structure of a) PGL and b) PLL. 
 
PLGA has been functionalized through the copolymerization of the relevant monomer with 
activated monomers to form materials with different architectures. Chen and coworkers synthesized 
a series of poly(N-isopropylacrylamide) and poly[(L-glutamic acid)-co-(γ-benzyl-L-glutamate)] 
diblock copolymers using sequentially radical polymerization and ROP312. PLL is a cationic 
polyelectrolyte constituted by the repetition of the aminoacids L-lysine along the backbone chain.  
It was reported to display pH-dependent solubility, limited circulation lifetime due to aggregation 
with oppositely charged biopolymers313,314. PLL with reactive amine groups on the side chain can 
be prepared through the ROP of ε-carbobenzoxy-L-lysine N-carboxyanhydride (ZLL-NCA) and 
further deprotection. The strategies reported to functionalize PLL were similar to those encountered 
with PLGA. Indeed the direct conjugation of the active molecule onto the pendant side chain of the 
polymer represented the easiest and most convenient approach302. Its applications include glass 
coating to promote cellular adhesion, drug delivery and cell micro-encapsulation144.  
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2. Ulvan, an innovative and biocompatible polysaccharide 
from renewable resources for biomedical applications. 
 
Abstract 
Polysaccharides represent an important class of natural polymers that possess features, such as 
biocompatibility, biodegradability, low cost and abundance in nature, which makes them good 
candidate for the preparation of scaffolds for biomedical applications. In the present thesis our 
interests was focused on ulvans, a new class of polysaccharides extracted from green algae 
belonging to Ulva species whose added value is represented by the possibility to obtain them from 
natural, abundant and renewable resources. Our aim was to test the feasibility of using this material 
as polymeric matrix for biomedical applications. To this purpose ulvan needs to be crosslinked in 
the form of three dimensional scaffold of appropriate porosity and water affinity to support cell 
metabolic functions. Two different strategies were undertaken to prepare ulvan-based hydrogels 
namely covalent and physical crosslinking. Covalent crosslinking was obtained by UV 
photopolymerization of the ulvan macromer after proper functionalization with methacryloyl 
groups. The same technique was used to conjugate bioactive molecules onto ulvan scaffold to 
enhance its biocompatibility. To this aim a molecule mimicking the Arginine-Glycine-Aspartic acid 
sequence (RGDm) containing a photopolymerizable group and the gelatin macromolecule grafted 
with methacryloyl groups were successfully employed. Ulvan-based scaffolds were easily obtained 
by physical crosslinking through the preparation of Polyelectrolyte Complexes (PECs) between 
ulvan and chitosan as components. Biological assays on these PECs provided the best results in 
term of cell viability and proliferation. The developed materials were thoroughly characterized by 
conventional methods to determine both the chemical modification occurring during crosslinking 
and the physical properties of the obtained hydrogels such as porosity, rheological behaviour and 
water affinity. Their biological properties were deeply investigated to test the feasibility of using 
these materials in biomedical applications. 
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2.1.  Introduction 
 
The growing attention for natural materials has been leading to a special focus on polysaccharides. 
They represent an important class of natural polymers that possess features which makes them good 
candidates for biomedical applications. The high biocompatibility and biodegradability and high 
number of functional groups into their structures that can be easily modified or tailored provide the 
material with the required functional and structural properties. Polysaccharides can be obtained 
from renewable resources preferably not interfering with food chain supply1. They perform 
different physiological functions and may offer a variety of potential applications in biomedical 
field2. For these reasons polysaccharides are gaining an important role in the field of biomaterials 
and have found applications as hydrogel matrices for cell encapsulation, drug delivery and as 
biologically friendly scaffold for tissue engineering2. Our interest was focused on ulvans, a class of 
polysaccharides with innovative structure and functional properties. They are extracted from the 
cell walls of marine green algae belonging to Ulva species1. The huge biomass would represent a 
valuable resource of materials since abundant and often involved in processes detrimental for the 
environment3. To date its exploitation is aimed to limited food consumption and its disposal is 
increasingly troublesome4. The low value associated to this biomass makes ulvans easily available 
from abundant and cheap renewable resources5. 
Ulvans polysaccharides are characterized by a heterogeneous chemical composition, which varies 
depending on several factors including the taxonomic and ecophysiological origins of the algal 
sources6 They are mainly composed of a disaccharide repeating unit containing an uronic acid such 
as D-glucuronic or D-iduronic acid, linked to L-rhamnose-3-sulfate (Figure 1)7. 
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   β-D-glucuronic acid (1→4)-α-L-rhamnose-3-sulfate             α-L-iduronic acid (1→4)-α-L-rhamnose-3-sulfate 
Figure 1. Chemical structure of ulvans. 
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These polysaccharides are supposed to be non toxic toward interfaced organisms since are widely 
reported to display a wide range of biological activities including antiviral8, anticoagulant9, 
antioxidant10 and antihyperlipemic11 properties. For such characteristics, ulvans could be considered 
promising materials for the preparation of scaffolds for biomedical application such as tissue 
engineering and drug delivery although they are still underexploited. Most of the applications of 
polysaccharides in the biomedical field require their use as insoluble material in the form of 
hydrogels. Hydrogels are hydrophilic networks of natural or synthetic polymer chains capable to 
absorb and retain large amounts of water. They possess a degree of flexibility very similar to natural 
tissue, due to their significant water content, that makes them good materials to be employed in a 
great variety of biomedical application. Common applications of hydrogels include regenerative 
medicine, tissue engineering and delivery of bioactive agents12-20. Natural materials have been 
widely investigated for hydrogel preparation and in particular polysaccharides due to their 
hydrophilicity, biodegradability and possibility to be easily functionalized with active molecules21-
25
. Polysaccharide-based hydrogels have been prepared by several methods involving the formation 
of chemical and physical crosslinks26. In this context, the crosslinking of polymers by radical UV-
induced polymerization would offer considerable advantages such as ease, rapidity, possibility to 
obtain hydrogels in situ by injectable systems, safety and low cost, over other chemical methods, 
which generally involve different reactive species, initiators and catalysts27. Therefore the 
preparation of ulvan-based hydrogels has been investigated by our research group by means of UV 
photopolymerization1. The condition for UV photopolymerization is that polymeric materials need 
to be conjugated with radically polymerizable groups. Methacryloyl groups have demonstrated a 
good candidate for this function as they work as degradable crosslinks sensitive to either 
hydrolysis28 or cell-mediated proteolysis29. However a functionalization with bioactive molecules 
was needed to improve the cellular attachment and proliferation on the surface of the scaffolds 
because the high hydrophylicity of ulvan did not facilitate the cellular adhesion.  
To this aim two strategies were investigated: 
 
1) Preparation of ulvan scaffolds by UV photopolymerization with added active molecules to 
enhance the biocompatibility of the material. The conjugation of the bioactive species was 
mediated by UV exposure of the solution containing the ulvan macromer and the bioactive 
molecule suitability modified with a UV sensitive group. 
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2) Preparation of scaffolds crosslinked by ionic interactions between ulvan and a bioactive 
polymer. Polyelectrolyte complexes (PECs) were prepared employing chitosan as cationic 
component in virtue of its reported biocompatibility and bioactivity30-36. 
 
 
2.2. Experimental part 
 
2.2.1. Materials 
Ulvan batch in powder was extracted by U. Armoricana and supplied by CEVA (Mw = 37 000 Da); 
all the other reagents were used as received. 
 
2.2.2. Methods 
 
2.2.2.1. Instrumental methods 
 
IR analysis 
FT-IR spectra were recorded as KBr pellets (1/100 mg) or as solution in KCl pellets, in the range of 
4000-400 cm-1 by using a Jasco FT-IR 410 spectrophotometer with a resolution of 4 cm-1. Each 
spectrum was recorded after 16 scans. 
 
UV-Vis analysis 
UV-Vis absorption spectra measurement were performed by JascoV-530 and UNICAM UV 500 
ThermoSpectronic spectrophotometers. The spectra were recorded in the range of 750-250 nm on 
samples in aqueous solution using pure water as reference. 
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1H-NMR analysis 
1H-NMR spectra were recorded on a Varian Gemini 200 spectrometer using a Sparc 4 (Sun) 
console and VNMR 6.1B software. Spectra were recorded on 1-2% (w/v) solutions, in deuterated 
water at 20 °C. 1H-NMR Spectra were recorded at 200 MHz. 
 
Rheological analysis 
The visco-elastic properties of the scaffolds were evaluated by using a Scientific RM5000 
Rheometer with parallel plates geometry. The parameters which describe the visco-elastic behavior 
are the shear storage modulus G’(ω) and the shear loss modulus G”(ω). G’ provides information 
about the elasticity or the energy stored in the material during deformation, whereas G” describes 
the viscous character or the energy dissipated as heat37,38. A dynamic frequency sweep test was 
conducted on the scaffolds swollen to equilibrium in PBS (1 M; pH = 7,4, scaffolds diameter 
approximately 17-18 mm), to determine its linear viscoelastic region. During a strain sweep test, the 
samples were subjected to an increasing stress (strain amplitude 0.01%-0.5%), while constant 
frequency (1 Hz) is maintained. Dynamic frequency sweep tests on the samples were performed in 
the range of 0.5-5 Hz. The tests were performed in the linear visco-elastic region (strain amplitude 
0.1%), where the values of G’ and G” are independent from frequency.  
 
Scanning Electron Microscopy (SEM) 
The surface and section morphologies of the scaffolds were recorded by using a JEOL (JSM-
5600LV) scanning electron microscope (SEM) at the required magnification and with accelerating 
voltage of 14kV. The samples were sputtered with gold before SEM observation.  
 
2.2.2.2. Synthesis of the ulvan-based scaffolds and their precursors 
 
Synthesis of ulvan methacrylate (UMA) 
Ulvan (2.4 g; 6 mmol of disaccharide repeating units; 18 mmol of reactive hydroxyl groups) was 
dissolved in 50 ml of water. After dissolution an excess of methacrylic anhydride (MA) (65 ml; 436 
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mmol) was added dropwise to the reaction mixture. A solution of NaOH 5N (19.62 g of NaOH in 
98.1 ml of water; NaOH/MA mol ratio =1.12) was added to the ulvan solution in order to keep the 
pH constant between 7 and 8. The reaction mixture was left under vigorous stirring for 120 min at 
room temperature and at 4 °C for 22 h. The product was purified by double precipitation from water 
solution into absolute ethanol (1/10 v/v). After centrifugation the product was washed with absolute 
ethanol, diethyl ether and then dried under vacuum. The obtained product was further purified by 
exhaustive dialysis against water and lyophilized for 24 h at -50 °C. Typical product yields ranged 
from 56 to 64%. The degree of substitution (DS; the number of methacrylate groups per 
disaccharide repeating units) was determined by 1HNMR, by calculating the ratio of the peak areas 
corresponding to the methyl groups of methacrylate (1.85 ppm) to those of rhamnose sulfate (1.22 
ppm). The maximum obtainable degree of substitution (DS) is 3, since every disaccharide repeating 
unit contains one rhamnose sulfate 3 hydroxyl reactive groups. Typycal obtained DS values ranged 
from 1 to 1.2. 
 
Synthesis of ulvan acrylate (UA) 
In a 100 ml round bottomed flask an aqueous solution containing ulvan (1 g; 2.5 mmol of 
disaccharide repeating units; 7.5 mmol of reactive hydroxyl groups), NaOH (2.91 g; 72.7 mmol) 
and 2-butanone (4 ml) was prepared at 0 °C. A solution containing acryloyl chloride (8 ml; 99 
mmol) in toluene (20 ml) was added dropwise to the reaction mixture at 0 °C. The obtained solution 
was left stirring at 0 °C for 3 h. The product was purified by double precipitation from water 
solution into absolute ethanol (1/10 v/v). After centrifugation the product was washed with absolute 
ethanol and diethyl ether. The suspension was filtered, washed with diethyl ether and the solvent 
was removed under vacuum. The obtained product was further purified by exhaustive dialysis 
against water, freeze dried for 28 h at -50 °C. Typical product yields ranged from 63 to 68%. The 
degree of substitution (DS; the number of methacrylate groups per disaccharide repeating units) was 
determined by 1HNMR, by calculating the ratio of the peak areas corresponding to the hydrogens of 
the acrylate groups (6.0, 6.2, and 6.4 ppm) to those of the methyl groups of rhamnose sulfate (1.22 
ppm) The maximum obtainable degree of substitution (DS) is 3, since every disaccharide repeating 
unit contains one rhamnose sulfate and 3 hydroxyl reactive groups. Typycal obtained DS values 
ranged from 0.2 to 0.3. 
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Synthesis of RGDm 
Agmatine sulfate (250 mg; 1.1 mmol) was dissolved in a 50 ml round bottomed flask containing a 
solution of 44.5 mg of NaOH and 13 ml of water (agmatine/NaOH molar ratio = 1/1). Itaconic 
anhydride (1.0 g) was slowly added to the solution and the pH was constantly adjusted to 7.4 by 
addition of an aqueous solution of NaOH (1 M). The reaction was allowed to progress for 23 h 
under intensive stirring at room temperature. At the end the pH of solution was adjusted to 3.0 with 
HCl(aq) 6N and the reaction mixture was extracted with ethyl acetate (50 ml x 3) to remove organic 
impurities. The aqueous solution was freeze dried at -50 °C thus obtaining a yellowish product 
whose spectral characterization confirmed the presence of the desired product. 1H-NMR (200 MHz, 
D2O) δ (ppm): 1.5-1.6(m, 4H, CH2), 3.1-3.4 (m, 6H), 5.5 (s, 1H, C=CH2), 6.2 (s, 1H, C=CH2). 
 
Synthesis of gelatine methacrylate (GelMA) 
Gelatin (1g; Type A; 175 bloom) was added to 10 mL of PBS (0.2 M; pH = 7.4) and heated at 50 
°C until all gelatin was dissolved. Methacrylic anhydride (33.8 mmol) was added dropwise to the 
stirring mixture and the reaction was allowed to proceed for 1 h at 50 °C. The reaction mixture was 
then dialyzed with a dialysis membrane (ester cellulose; MWCO = 10,000) for 1 week against H2O 
to remove impurities. The solution was then lyophilized at -50 °C thus providing a white sold 
(Yield: 78%). The degree of substitution (DS) defined as the percentage of methacrylate groups 
with respect to the total aminoacidic units of gelatin was determined by 1HNMR, according the 
formula: 
 
DS% = [( Pphe  x  AMA) / Aphe] x 100                                                 [1] 
 
where Pphe is the percentage number of phenylalanine residues present in gelatin39, AMA is the 
normalized peak areas corresponding to the olefinic hydrogens of methacrylate; Aphe is the 
normalized peak areas corresponding to aromatic hydrogens of phenylalanine. The maximum 
obtainable value is 3.7% calculated by considering the most common aminoacidic compositon of 
gelatin reported in literature39. The experimental value obtained by using the equation [1] was 3.7% 
thus indicating an almost complete reactivity of gelatin towards methacrylic anhydride. 
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Conjugation of GRGDS on Ulvan. 
Ulvan (500 mg; 1.25 mmol of disaccharidic units) was dissolved in a 100 ml round bottomed flask 
containing an aqueous solution (40 ml) of MES ( 0.1 M; pH = 5.15) and NaCl (0.3 M). EDC (12 
mg; 0.0625 mmol; 5% mol/mol respect to carboxylic groups) and sulfo-NHS (6.78 mg; 0.0312 
mmol; 2.5% mol/mol respect to carboxylic groups) were dissolved in a separate solution of MES 
(0.1 M, pH=5.15)/NaCl (0.3 M) and added to the solution containing ulvan. The reaction mixture 
was left stirring at room temperature for 15 minutes to allow the activation of carboxyl groups of 
ulvan. Subsequently the pH was adjusted to 7.36 by using PBS solution (1 M, pH = 7.4) and a 
solution containing GRGDS (0.5 mg; 0.001 mmol) in 0.5 ml of water was added. The reaction 
mixture was kept stirring at room temperature for 24 h after which the product was purified by 
dialysis (ester cellulose membrane; 10,000 MWCO) against H2O for four days and lyophilized until 
dried, furnishing a white solid (Yield: 40%). 
 
Purification of ulvan by Proteinase K 
In a 25 ml two necked round bottomed flask 500 mg of ulvan were dissolved in 15 ml of water. A 
solution of proteinase K (1.6 mg in 1 ml of water) was added. The reaction mixture was stirred at 50 
°C for 22 h and then at 100 °C for 15 minutes in order to deactivate the proteinase K. The solution 
was once precipitated in ethanol (95%) and in absolute ethanol three times. After centrifugation the 
solid was collected and washed with diethyl ether, filtered and dried under vacuum. The product 
was recovered with a yield of 39%. 
 
UV crosslinking of ulvan (meth)acrylate 
Hydrogels based on UMA or UA were prepared starting from aqueous solutions containing the 
respective macromers (5% w/v) and the cytocompatible UV photoinitiator IRGACURE® 2959 
(0.25% w/v). The obtained viscous solutions were equally distributed in a 24 wells microplate and 
exposed to a UV light source (mercury vapor lamp, 8-10mW/cm2, wavelength: 365 nm). The 
obtained hydrogels were lyophilized at -50 °C for 24 h in order to obtain the dried scaffolds. 
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UV crosslinking of ulvan methacrylate with RGDm 
Photocrosslinked RGDm-UMA-based hydrogels containing different amount of RGDm were 
prepared starting from aqueous solutions containing UMA (5% w/v), the cytocompatible UV 
photoinitiator IRGACURE® 2959 (2.5% w/v) and different concentration of RGDm. The obtained 
viscous solutions were equally distribuited in a 24 wells microplate and exposed to a UV source 
(mercury vapor lamp, 8-10mW/cm2, wavelength: 365 nm) for 10-15 minutes. The obtained 
hydrogels were dried lyophilized at -50 °C for 24 h. The presence of RGDm linked to the scaffold 
were qualitatively evaluated by Sakaguchi assay37. 
 
Photo-co-polymerization of ulvan methacrylate and gelatin methacrylate. 
Photo-co-polymerization of Ulvan methacrylate (UMA) and gelatin methacrylate (GelMA) was 
performed starting from two separate aqueous solutions containing UMA (5% w/v) and the 
cytocompatible UV photoinitiator IRGACURE® 2959 (2.5% w/v) and GelMA (8% w/v) with 
IRGACURE® 2959 (0.6% w/v).  In 5 test tubes, pre-determinate amounts of UMA solution were 
mixed with different amount of GelMA solutions in order to obtain the following weight ratio 
between the two components: UMA/ GelMA = 100/0, 75/25, 50/50, 25/75 and 0/100. The obtained 
viscous solutions were equally distribuited in a 24 wells microplate and exposed to a UVsource 
(mercury vapor lamp, 8-10mW/cm2, wavelength: 365 nm) for 10 minutes. The obtained hydrogels 
were dried lyophilized at -50 °C for 24 h. 
 
Synthesis of ulvan/chitosan-based PECs 
Cylindrical shaped PEC hydrogels containing ulvan and chitosan were prepared into each well of a 
24-well tissue culture plate. The suitable amount of chitosan powder was separately weighed and 
added into each well. Ulvan solutions having different concentrations according to the envisaged 
PEC compositions were separately prepared and a constant volume was poured to each separate 
well yet containing chitosan powder. The total weight percentage of chitosan and ulvan in the 
prepared solutions was 5%. Acetic acid 1% (v/v) was added to each solution to dissolve chitosan 
powder and the mixture was vigorously stirred until obtaining a homogeneously dispersed hydrogel. 
The hydrogels were left standing at room temperature for 24 hours to favour the maximum 
interactions between the constituting polymeric chains and then freeze dried under vacuum (0.04 
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mbar) at -50°C to remove the excess of water. Further treatments of the dried scaffolds varied 
according to the envisaged applications and are specified in the dedicated sections. The scaffolds 
were prepared according to four different weight percent compositions: ulvan/chitosan = 70/30, 
60/40, 40/60 and 20/80. 
 
2.2.2.3. Chemical, physical and biological characterization of the ulvan-based scaffolds 
 
Sakaguchi assay 
The reagents used in this assay were prepared according to the procedure reported in literature37:  
arginine standard solution (0.05-0.5 mg/ 100 ml of water); sodium hydroxide (NaOH) solution 10% 
(w/v). 1-naphthol solution 0.02% (w/v): 20 mg of 1-naphthol in 10 ml of ethanol (95%) were 
diluted to 50 ml with water; sodium hypobromite (NaBrO) solution: 161 µl of NaBrO in 25 ml of a 
solution of NaOH(aq) 5% (w/v); urea solution 40% (w/v). The 1-naphthol and hypobromite solutions 
were kept in the dark. The assay was performed according to the following procedure: 1 ml of the 
NaOH solution and 1 ml of the 1-naphtol solution were added to 5 ml of aqueous solution 
containing the sample to be analyzed. After the solution was stirred for a brief period 0.1 ml of the 
solution containing NaBrO and 1 ml of the urea solution were added. The obtained solution was 
analyzed by UV-Vis spectroscopy. The GRGDS concentration on ulvan was determined by using a 
calibration curve obtained by plotting the absorbance at 490 nm of the standard arginine solutions 
(0.05-0.5 mg/ 100 ml) vs. their concentration in mg/ml (R2 = 0.997). 
 
Qualitative evaluation of RGDm linked to UMA-based hydrogels by Sakaguchi assay 
The reagents used in this assay were prepared according to the procedure reported in literature37:  
arginine standard solution (0.05-0.5 mg/ 100 ml of water); sodium hydroxide (NaOH) solution 10% 
(w/v). 1-naphthol solution 0.02% (w/v): 20 mg of 1-naphthol in 10 ml of ethanol (95%) were 
diluted to 50 ml with water; sodium hypobromite (NaBrO) solution: 161 µl of NaBrO in 25 ml of a 
solution of NaOH(aq) 5% (w/v); urea solution 40% (w/v). The 1-naphthol and hypobromite solutions 
were kept in the dark. The hydrogel samples were extensively washed in PBS (0.1 M, pH = 7.4) 
before the assay in order to remove the RGDm not covalently linked to the scaffolds. The procedure 
was as follows: the hydrogels were put in a 12 wells microplate and immersed in a solution 
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containing 1.5 ml of the NaOH solution and 1.5 ml of the 1-naphtol solution. After shaking the 
support for a short time, 150 µl of the solution containing NaBrO and then 1.5 ml of the urea 
solution were added. A red discoloration confirmed the presence of the RGDm on the surface of the 
scaffolds. 
 
Hydrogel swelling degree mesurements 
The dried scaffolds (circular shape, diameter = 17-18 mm; approximately 30 mg for each scaffold) 
were swollen in PBS solution (0.1 M; pH = 7.4) and weighted at regular time intervals after 
removal of excess surface liquid by blotting with a soft tissue. The swelling degree (SD%) was 
calculated as 
SD% = [(Ws – Wd)/Wd] x 100 
Ws represent the weight of the swollen sample and Wd the weight of the dry sample. The 
experiments were performed in double and the SD% reported as mean. 
 
Biological evaluation of RGDm/UMA- or GelMA/UMA-based hydrogels 
Ulvan based hydrogel samples, placed in 12 wells plates, were sterilized under UV light for 40 
minutes for each side. Cell viability and proliferation assays were carried out using the 3T3/BALB-
C Clone A31 mouse embryo fibroblast cell line. Cells were grown in Dulbecco's Modified Eagles 
Medium (DMEM) containing 10% bovine calf serum, 4 × 10−3M of glutamine, penicillin (100 
U · ml−1) and streptomycin (100 µg · ml−1) (complete DMEM). A subconfluent monolayer of 
3T3/BALB-C Clone A31 fibroblast was trypsinized using a 0.25% trypsin 1 mM EDTA. Cells were 
centrifuged at 1000 rpm for 5 min, re-dispersed in complete DMEM and counted. Cells were seeded 
at an appropriate density (1 x 105cells/mL) directly on hydrogels and allowed to proliferate at 37°C 
in humidified atmosphere containing 5% CO2 for 72 hours. At the end of the exposure time, cell 
viability was measured by means of WST-1 assay. The assay was performed by incubating cell-
seeded hydrogels with WST-1 reagent diluted 1:10 for 4 hours at 37°C and 5% CO2. Formazan 
production was detected at 450 nm, with 620 nm as reference wavelength, using a Biorad 
Microplate Reader. 
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Biological evaluation of ulvan/chitosan-based PECs 
Prior to biological investigations PECs were sterilized under UV light, for 30 minutes on each side. 
Sample were incubated in Dulbecco's Modified Eagles Medium (DMEM) at 37 °C and 5% CO2 for 
24 hours prior to cell seeding. Then BALB/3T3 Clone A31 mouse embryo fibroblast cell line was 
seeded (density 2 x 104cells/mL) onto hydrogel and allowed to proliferate in appropriate growing 
conditions. After 3, 7, 14 and 21 days, cell viability was measured by Alamar-Blue® assay 
performed by incubating cell-seeded hydrogels with Alamar-Blue® reagent diluted 1:10 for 24 
hours. Measurements of resorufin dye absorbance were detected at 565 nm, with 595 nm as 
reference wavelength, using a Biorad Microplate Reader. To confirm preliminary results, live/dead 
viability assay was performed by incubating the scaffolds with a solution of calcein AM (2µM) and 
ethidium homodimer-1 (2µM) in PBS (pH =7.4, 0.01 M) for 30 minutes at 37°C. The numbers of 
live (green) and non viable/dead (red) cells were immediately assessed using a Nikon Eclipse 
TE2000 inverted microscope equipped with an EZ-C1 confocal laser (Nikon, Japan). Cell 
morphology and adhesion on prepared hydrogels was investigated by Confocal Laser Scanning 
Microscopy at 21 days of culture. Cells were fixed with 3.8% paraformaldehyde for 1 hour, 
permeabilized with a PBS 1X/Triton X-100 and then incubated with a solution of Phalloidin-
Rhodamine B isothiocyanate an 4’-6-diamidino-2- phenylindole (DAPI) in PBS/BSA 1% for 45 
minutes at room temperature in the dark. A Nikon Eclipse TE2000 inverted microscope equipped 
with an EZ-C1 confocal laser (Nikon, Japan) was used to analyze the sample. 
 
 
2.3. Results and discussion 
 
2.3.1 Preparation of ulvan-based hydrogels by UV photopolymerization and 
their characterization 
Several procedures are reported in literature for the preparation of hydrogels, involving the 
formation of both chemical and physical crosslinks26. In this context, the chemical crosslinking of 
polymers by radical UV-induced polymerization offers considerable advantages such as ease, 
rapidity, safety and low cost27. This technique has been widely investigated for the preparation of 
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hydrogels from different polymeric materials26. At the best of our knowledge only our research 
group has been actively involved in the preparation of ulvan-based hydrogels by UV-
photopolymerization1. To this aim the introduction of photopolymerizable groups within ulvan 
structure was necessary for the covalent crosslinking of this materials under UV irradiation. 
Methacryloyl or acryloyl groups represented the most commonly used moieties in this kind of 
applications to provide the conjugated material with the proper sensitivity to UV light26,40. 
Therefore two different ulvan macromers were prepared both containing a UV polymerizable group 
such as ulvan-acrylate (UA) and ulvan-methacrylate (UMA) as suitable precursors for the 
preparation of UV crosslinked hydrogels. 
 
2.3.1.1. Functionalization of ulvan with (meth)acryloil groups 
Following the procedure previously optimized in our research laboratory1, UMA was synthesized 
by esterification of the hydroxyl groups of ulvan with methacrilyc anhydride in mild basic 
conditions. The reaction was carried out under basic conditions in order to drive the equilibrium 
between ulvan and methacrylic anhydride to the formation of UMA macromer by the neutralization 
of the forming methacrylic acid (Scheme 1). A molar excess of methacrylic anhydride with respect 
to the ulvan hydroxyl groups was used to compensate for the tendency of methacrylic anhydride to 
be hydrolized to the corresponding diacid. The pH of the reaction medium was kept between 7 and 
8 by the addition of a NaOH solution until a final 1.12 molar ratio of NaOH/methacrylic anhydride 
was reached. A gradual addition of NaOH was necessary to avoid an abrupt raise both in the pH and 
the temperature of the reaction medium, which could lead to the hydrolysis of the ester linkage 
eventually formed and/or the polymerization of the methacryloyl groups. 
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Scheme 1. Synthesis of ulvan methacrylate. 
 
The reaction solution was left under stirring at 4°C for 24 h in order to minimize the basic 
hydrolysis of the ester linkages just formed and to avoid polymerization of the methacryloyl groups 
present in solution. The successful incorporation of methacrylate on ulvan was confirmed by IR and 
1H-NMR spectroscopy. The IR spectra of ulvan and the modified ulvan (Figure 2) were almost 
superimposible, except for the peak at 1718 cm-1 relative to the C=O stretching vibration 
characteristic of unsaturated carboxylic ester group. The peak relative to the C=C stretching 
vibration of the methacrylic group was not detected as it overlapped the strong absorption band at 
1629 cm-1 of the carboxyl groups of ulvan41. 
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Figure 2. FT-IR spectra of ulvan and UMA. In the red box is evidenced the absorption peak at 1718 cm-1 relevant to 
the presence of an α,β-unsatured carbonyl group in the investigated polymer. 
 
The 1H-NMR spectrum of UMA (Figure 3B) showed several distinctive peaks in the double bond 
region (5.5–6.5 ppm) and at 1.85 ppm, which were not present in the native ulvan (Figure 3A). Two 
distinctive peaks at 5.65 and 6.12 ppm were attributed to the two protons linked to the vinylidenic 
double bond (–C=CH2) and the peak shown at 1.85 ppm, ascribed to the methyl groups adjacent to 
the double bond (CH3–C=CH2). 
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Figure 3. 1H-NMR spectra of a) ulvan and b) UMA in deuterated water (D2O). 
 
Typical degree of substitutions of the obtained UMA (DS; number of methacrylate groups per 
disaccharide repeating units), determined by calculating the ratio of the peak areas corresponding to 
the methyl groups of methacrylate to those of rhamnose sulfate, were found to be in the range of 1-
1.1. Ulvan acrylate (UA) was synthesized by following a similar procedure using acryloyl chloride 
as precursors (Scheme 2)42. 
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Scheme 2. Synthesis of ulvan acrylate.  
 
The reaction was performed in hetrerogeneouus conditions through addition of a toluene solution of 
acryloyl chloride (9.7 equivalent respect to the ulvan reactive groups) to the aqueous solution of 
ulvan. 2-butanone was added to favor the compatibility of the two phases. The excess of acryloyl 
chloride and the low temperature (0 °C) of reactions were used to compensate the tendency of the 
acryloyl precursor to be hydrolized to the acidic compound. The IR spectrum of UA (Figure 4) 
showed the peak at 1724 cm-1 (C=O stretching vibration of unsaturated ester bond) confirming the 
successful incorporation of acrylate on ulvan. 
 
Figure 4. FT-IR spectra of Ulvan and UA. In the red box is evidenced the absorption peak at 1724 cm-1 relative to the 
presence of an α,β-unsatured carbonyl group in the highlighted polymer. 
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The 1H-NMR spectrum of UA (Figure 5B) showed three distinctive peaks in the double bond region 
(5.5–6.5 ppm) corresponding to the three olefinic protons of the acryloyl group conjugated to ulvan 
(–CH=CH2). 
 
Figure 5. 1H-NMR spectra of a) ulvan and b) UA in D2O. 
 
The desired product was obtained with a good yield but the DS of acrylic groups (number of 
acrylate groups per disaccharide repeating units), determined by calculating the ratio of the 1H-
NMR peak areas corresponding to the vinilic hydrogens of acrylate (5.5-5.6 ppm) to those of the 
69 
 
methyl group on the polysaccharide chain (1.22 ppm), resulted lower (0.2-0.3) with respect to 
UMA. 
 
2.3.1.2. Photopolymerization of ulvan (meth)acrylate 
The introduction of vinyl polymerizable groups within the polysaccharides structure allows for the 
covalent crosslinking of these materials under UV irradiation through a radical polymerization 
mechanism. This procedure was previously optimized by our research group for the preparation of 
ulvan-based hydrogels1. UMA and UA were cured as viscous aqueous solutions (5% w/v) 
containing a low amount (0.25% w/v) of a cytocompatible43 photoinitiator (IRGACURE 2959®). 
under a UV source (λ = 365 nm) for 10 minutes1. The polymeric chains of the macromers would 
form a crosslinked network through multiple covalent linkages between the double bonds of the 
(meth)acryloyl groups triggered by UV light through a radical mechanism (Scheme 3). 
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Scheme 3. UV photopolymerization mechanism of UMA and UA.  
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2.3.1.3. Characterization of (meth)acryloil group conversion 
The extent of crosslinking inside a scaffold represents a key parameter to be evaluated, since it 
affects the physical properties44 of the obtained hydrogels and their potential field of applications45. 
The degree of crosslinking of UMA- and UA-based hydrogels was measured by 1H-NMR analysis. 
Several solutions containing ulvan (meth)acrylate (5% w/v) and the photoinitiator IRGACURE 
2959® (0.25% w/v) in deuterium oxide were photopolymerized directly in an NMR tube under a 
UV source and the crosslinked samples were analyzed at different times of exposure. The 
vinylidenic group conversion was monitored by comparing the intensity of the peaks relative to the 
protons of the reacting double bonds (5.6-6.5 ppm) with the aromatic peaks of the photoinitiator 
used as internal reference (7.0 and 8.1 ppm)46. The 1H-NMR spectrum of the initial solution 
containing uncrosslinked UMA and IRGACURE 2959® was used as a reference for the calculation 
of the degree of crosslinking of vinyl groups. The main drawback of this technique was the lack of 
resolution of the obtained spectra due to the high viscosity of the analyzed samples. However the 
obtained results gave us a significant estimate of the extent of crosslinking occurring during UV 
irradiation (Table 1). 
 
                 UV exposure time (min)                        Crosslinking degree (%) 
       Methacrylated ulvan   Acrylated ulvan 
5                     46                  58 
10 64 73 
20 82 100 
 
Table 1. Degree of crosslinking obtained for UMA- and UA-based hydrogel as a function of exposure time. DS of the 
analyzed materials: UMA = 1-1.2; UA = 0.2-0.3. 
 
The observed behavior can be interpreted by considering both the different degree of substitution of 
the two macromers and the higher reactivity of acrylate with respect to methacrylate groups towards 
radical polymerization47. Although the kinetics of reaction of the double bond of UA resulted faster 
the relevant hydrogels were characterized by a lower extent of crosslinking due to their lower 
functionalization. 
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2.3.1.4. Swelling degree measurement 
The swelling ability of hydrogels in physiological conditions is usually determinant in regulating 
many of their properties, such as permeability to hydrophilic or hydrophobic drugs, 
biocompatibility, rates of enzymatic or hydrolytic degradation, and mechanical properties. 
Conventionally it is calculated as swelling degree (SD%). SD% could indirectly provide 
information about the mechanical stability and the chemical and physical properties of hydrogels, 
since the degree of water uptake is related both to the chemical nature and to the physical structure44 
of the polymeric network. It is known44, for example, that gels exhibiting a larger pore structure 
have poor mechanical strength and higher swelling ratios. Swelling degree investigation (SD%) was 
carried out both on UV photocrosslinked UMA and UA samples by using PBS (0.1 M; pH=7.4) as a 
medium (Figure 6). PBS was chosen as medium because its ion content and pH is close matching 
those encountered in human body. 
 
 
Figure 6. Swelling degrees (SD%) of ulvan methacrylate (UMA)- and ulvan acrylate (UA)-based hydrogel. UV 
exposure time: 10 minutes. The SD% were calculated as SD% = [(Ws – Wd)/ Wd] x 100 where Ws is the weight of the 
swollen sample and Wd the weight of the dry sample. 
 
The swelling degree obtained for both ulvan hydrogels are reported in Figure 6 as SD% values and 
calculated according to equation [2]:  
 
SD% = [(Ws – Wd)/ Wd] x 100                                                  [2] 
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where Ws is the weight of the swollen sample and Wd the weight of the dry sample taken at 
different time intervals. The SD% values of both UMA and UA-based hydrogels reached a plateau 
after 5 hours of incubation the medium. Both samples displayed high SD% values indicating the 
high water absorption capability of ulvan. No relevant differences of SD% values between UA and 
UMA were detected despite the different degree of crosslinking46. The UA-based hydrogels were 
expected to absorb a larger amount of water at the equilibrium due to their lower degree of 
substitution and lower intrinsic hydrophobicity provided by the acrylate with respect to 
methacrylate group48. The exponential behavior could be interpreted by considering the mechanical 
instability of UA hydrogels that make them difficult to handle and prone to physical rupture. The 
higher stability of the UMA-based hydrogels prompted us to investigate more in depth these 
materials for our purpose. The swelling behaviors of these samples were measured by varying their 
exposition time to UV source (Figure 7). 
 
 
Figure 7. Swelling degree of UMA-based hydrogel crosslinked at different time intervals of UV exposure. The SD% 
were calculated as SD% = [(Ws – Wd)/ Wd] x 100   where Ws is the weight of the swollen sample and Wd the weight of 
the dry sample. 
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The results showed that hydrogels prepared according to lower times of exposition to UV light 
displayed higher SD% values. Indeed the lower degree of crosslinking would result in higher 
affinity towards water and a lower physical resistance towards swelling. The similar SD% values 
displayed by the scaffold prepared after 8 and 12 minutes of exposition to UV light, suggested a 
limiting effect of the crosslinking density upon the swelling behaviour of the hydrogels after very 
few minutes of treatment. 
 
2.3.1.5. Rheological analysis 
Mechanical properties are critical criteria to judge the feasibility of a hydrogel for a specific 
biological application49-51. Available materials should possess enough strength to sustain cell 
growth while appropriate mechanical stiffness is essential for regulation of cell phenotype, cell 
adhesion and cell gene expression52. The investigated parameters which describe the visco-elastic 
behavior of the analyzed hydrogels are the shear storage modulus G’(ω) and the shear loss modulus 
G”(ω). G’ provides information about the elasticity or the energy stored in the material during 
deformation, whereas G” describes the viscous character or the energy dissipated as heat53,54. 
Dynamic frequency sweep tests were performed in the range of 0.5-5 Hz on the hydrogel samples 
swollen to equilibrium in PBS (pH = 7,4; 0.1 M). In view of possible applications it can be 
considered that this range includes typical frequencies of physiological activities of knees ranging 
from 0.5 Hz (walking) to 3 Hz (running)53,54. The test were performed in the linear viscoelastic 
region (strain amplitude 0.1%), where the values of G’ and G” are independent from frequency. The 
results showed that G’ of all hydrogels were greater than G” within the frequency range analyzed 
(Figure 8) reflecting a more elastic, rather than a viscous, behavior. Accordingly the rheological 
behavior of the obtained ulvan hydrogels were evaluated and the effect of the different crosslinking 
degree were investigated by varying the time of UV exposure of the relevant macromers solutions. 
The analyses were conducted exclusively on UMA-based hydrogels since UA samples were 
physically unstable. 
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Figure 8. Frequency sweep analysis (0.5-5 Hz) of UMA based hydrogels. DS of UMA: 1-1.2.  
 
As expected, the mechanical properties of the obtained hydrogels were affected by the extent of 
their crosslinking55 since the G’ values were found to increase with the UV exposition. In 
conclusion UMA-based hydrogels showed the features of “gel-like” material, with a predominantly 
elastic behavior, that made them good candidate for biomedical purposes. The rheological behavior 
of the hydrogels can be easily tuned according to the envisaged application by simply varying the 
time of exposition to UV light.  
 
2.3.1.6. Scanning electron microscopy (SEM) analysis 
The porosity of the scaffolds plays an important role in directing tissue formation and function56-58. 
A substantial scaffold porosity is often necessary to allow for homogeneous cell distribution and 
interconnection throughout engineered tissues. In addition, increased porosity can have a beneficial 
effect on the diffusion of nutrients and oxygen, especially in the absence of a functional vascular 
system57. The degree of porosity will also have a substantial effect on the mechanical properties, 
with the stiffness of the scaffold decreasing as porosity increases59. The porosity extent and 
interconnectivity play a significant role in cell survival, proliferation and differentiation60,61. The 
pore interconnectivity allows for cell ingrowth, vascularization, and nutrient diffusion for cell 
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survival62-64. The extent of ECM secretion also increases by increasing the pore size61. The porosity 
of the UMA-based hydrogels was analyzed by scanning electron microscopy SEM (Figure 9).  
 
 Before mechanical stress After mechanical stress 
             
 a) crosslinking time = 4 minutes b) crosslinking time = 4 minutes  
             
 c) crosslinking time = 8 minutes    d) crosslinking time = 8 minutes  
             
 e) crosslinking time = 12 minutes  f) crosslinking time = 12 minutes  
 
Figure 9. SEM analysis of the surfaces of UMA-based hydrogels taken at different crosslinking time. DS of UMA: 1-
1.2. Analysis was performed both on native (a, c and e) and mechanically stressed scaffolds (b, d and f). Applied 
mechanical stress: dynamic frequency sweep tests (strain amplitude: 0.1%, frequence range: 0.5-5 Hz). 
 
The analysis was performed on both the native and mechanically stressed hydrogels prepared at 
different UV light exposure time in order to investigate the effect of different crosslinking degree 
and applied mechanical stress on the material porosity. Mechanical stress derived from the 
rheological analysis according to the conditions described into paragraph 2.3.1.5. Native hydrogels 
presented an interconnected, three-dimensional porous network structure with pores of about 100 
µm size. The pore structure of native hydrogels seemed to be affected mainly by the sample 
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dehydration method and not by the crosslinking density although a denser structure has been 
recorded for hydrogels exposed to 12 minutes of UV irradiation. SEM analysis on the mechanically 
stressed hydrogels revealed that porosity was almost unaltered and not affected by external stimuli 
thus confirming the elastic behavior of analyzed hydrogels. 
 
2.3.1.7. Strategies to enhance cellular attachment and proliferation on ulvan-based hydrogels. 
The interaction of a material surface with cells is of critical importance in biomedical applications. 
It strongly determines cell attachment, spreading behavior, proliferation and differentiation65. The 
chemical and physical properties of the surface, such as its hydrophilicity, roughness, 
microstructure and mechanical properties66 represent key parameters to be optimized to favor the 
interaction between cells and materials. An effective way of promoting cell attachment is to change 
the morphology of the material, for example by introducing pores (as in foams or non-woven mats) 
or by employing patterned surfaces67,68. The most common approach to enhance cells affinity 
towards the investigated material is conventionally the immobilization of biomolecules such as 
growth factors and cell adhesive peptides (e.g. containing the sequence RGD)69-71. Our attention 
was focused on the functionalization of ulvan with bioactive molecules, since this material was not 
expected to favor cell adhesion due to its highly hydrophilic and charged nature. Indeed it is known 
that very hydrophilic materials can reduce cell attachment and proliferation72. To this aim ulvan was 
conjugated through its carboxyl group to bioactive molecules containing the Arginin-Glycine-
Aspartic acid (RGD) peptide sequence, or through UV photopolymerization to an RGD analogue 
containing a methacryloyl group or to gelatin properly functionalized with a radical polymerizable 
moiety. 
 
 
2.3.1.7.1. Preparation of ulvan-(meth)acrylate conjugated to an Arginine-Glycine-Aspartic 
acid (RGD) sequence 
2.3.1.7.1.1. Advantages of RGD peptides for enhancing cell/biomaterial interaction. 
The RGD sequence (Figure 10) is by far the most effective and most often employed peptide 
sequence for stimulating cell adhesion on biomaterial’s surfaces73,74. This is based upon its 
widespread distribution and use throughout the organism, its ability to address more than one cell 
adhesion receptor, and its biological impact on cell anchoring, behavior and survival. In 
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multicellular organisms, contacts of cells with neighboring cells and the surrounding ECM are 
mediated by cell adhesion receptors.  Among them the integrin family comprises the most 
numerous and versatile group.  The RGD sequence is reported to bind to multiple integrin species 
thus favoring cell adhesion and spreading75. Synthetic RGD peptides offer several advantages for 
biomaterials applications because integrin receptors recognize RGD as a primary sequence 
(although conformation of the peptide can modulate affinity)76. 
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Figure 10. Chemical structure of RGD. 
 
Moreover cell adhesive RGD sites were identified in many other ECM proteins, including 
vitronectin, fibrinogen, collagen, laminin, osteopontin, tenascin and bone sialoprotein as well as in 
membrane proteins, in viral and bacterial proteins, and in snake venoms (neurotoxins and 
disintegrins)77. Apart from RGD, other important cell adhesion motifs have been identified such as 
Isoleucine-Lysine-Valine-Alanine-Valine (IKVAV); Proline-Histidine-Serine-Arginine-Asparagine 
(PHSRN) or Lisine-Glutamine-Alanine-Glycine-Aspartic acid-Valine (KQAGDV). Therefore the 
RGD sequence is not the “universal cell recognition motif”, but it is nevertheless unique with 
respect to its broad distribution and usage. An exhaustive literature has established that RGD is 
highly effective at promoting the attachment of numerous cell lines to diverse type of polymeric 
materials78. An advantage of using the RGD sequence instead of the native ECM proteins in 
biomedical applications, is the minimization of the risk of immune reactivity or pathogen transfer76. 
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Moreover RGD containing peptides can be bonded to material surfaces in controlled densities and 
orientations. A very little amount of the peptide is needed to obtain a good cell attachment and 
spreading. Substrates investigated for cell adhesion and compatibility79,80 were successfully 
prepared with an RGD content ranging between 10-1 fmol/cm2 and 104 fmol/cm2 with a maximal 
cell spreading at the value of 1 fmol/cm2. 
 
2.3.1.7.1.2. Conjugation of ulvan with Glycine-Arginine-Glycine-Aspartic acid-Serine (GRGDS). 
Stable linking of RGD peptides to a surface is essential to promote strong cell adhesion. To this 
aim, RGD peptides should be covalently attached to the ulvan via functional groups like hydroxyl-, 
or carboxyl groups. In most cases RGD peptides are linked to polymers via a stable covalent amide 
bond. This is usually done by reacting an activated surface carboxylic acid group with the 
nucleophilic N-terminus of the peptide. Carboxylic acid groups can be activated by using a peptide 
coupling reagent, e.g. 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC), also referred to as 
water soluble carbodiimide, (WSC), dicyclohexyl-carbodiimide (DCC) or carbonyl diimidazole 
(CDI). Since Ulvan is only soluble in water we used EDC to link the pentapeptide Glycine-
Arginine-Glycine-Aspartic acid-Serine (GRGDS) (Figure 11) to the polysaccharide.  
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Figure 11. Chemical structure of GRGDS. 
 
79 
 
The procedure was carried out according to a sequential two steps process. The carboxylic groups 
of the polysaccharide were previously activated with EDC and N-hydroxysulfosuccinimide (sulfo-
NHS) (Scheme 4)81, in a slightly acidic environment (2-(N-morpholino)ethanesulfonic acid (MES) 
buffer; pH = 5.15). The addition of sulfo-NHS was needed to stabilize the reactive EDC-
intermediate against a competing hydrolysis reaction, raising the efficiency of amide bond 
formationi. 
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Scheme 4. Conjugation of ulvan with GRGDS. 
The second step of the process was the nucleophilic addition of the RGD containing peptide to the 
activated carboxylic group of ulvan. However, prior to GRGDS addition, the pH of the reaction 
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mixture was raised to 7.4 by addition of phosphate buffer solution in order to increase the activity of 
the amine group of the peptide81,82. The product was purified by dialysis against water. 1HNMR 
analysis of the product did not reveal the presence of peaks relative to GRGDS, due to the 
intrinsically low instrumental sensivity. A more specific and sensitive analysis,  needed to detect the 
presence of the RGD containing peptide inside the ulvan structure, is reported by following. 
 
2.3.1.7.1.3. Analysis of GRGDS contents: Sakaguchi assay 
The quantitative analysis of the GRGDS conjugated to ulvan was performed by a colorimetric 
method based on the specific detection of the guanidine group present in the pentapeptide. This 
method, based on modifications of the original Sakaguchi assay83,84, was selected in virtue of its 
reported specificity and sensibility83,85. The Sakaguchi assay is based on a sensitive and specific 
reaction between a guanidine group and 1-naphtol in presence of hypochlorite that usually leads to 
the formation of an intense red complex85. The main drawback of this method was the variability of 
the intensity of the colour during the assay that leads to not reproducible experiments. In the present 
work it was firstly decided to follow the most recent modification of this assay (Swenzer et al.84) 
but the modified technique proved to be unsuccessful in terms of accuracy and reproducibility. A 
second modification based on Weber method37, was investigated. According to this procedure the 
samples were treated with solution of 1-naphtol and hypobromide and urea in basic condition and 
analyzed by UV at 490 nm. A red coloured solution indicated the positivity of the assay. In this case 
the red discoloration proved to be more stable during time and this method was selected for the 
quantitative analysis of the peptide. Arginine was used as standard as widely reported in the Weber 
method applied for the determination of the arginine content of most proteins37. The standard 
solutions had to be freshly prepared in order avoid the decrease of the concentration of the 
guanidinium group recorded during the storage time, due to the guanidine carbonatation86. This 
method provided good results in terms of accuracy and linearity between absorbance and 
concentration values of the standard solutions. Analysis of a ulvan-GRGDS and ulvan blank 
samples proved unsuccessful due to the presence of small amounts of contaminating proteins6,38,87 
in the polysaccharide that hampered the determination of the low GRGDS contents (Figure 12). 
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Figure 12.UV-Vis absorption spectra of Sakaguchi products. Blue spectra: arginine standard solutions; red spectrum: 
ulvan-GRGDS; green spectrum: native ulvan. 
 
An enzymatic digestion was performed on native ulvan as an attempt to eliminate the protein 
contamination. Proteinase K was selected as hydrolytic enzyme according to a procedure reported 
for the purification of polysaccharides from green algae88. However the Sakaguchi assay carried out 
on the digested ulvan material evidenced the ineffectiveness of this purification procedure maybe 
due to inherent strong linkage between the polysaccharide and proteins89. Furthermore the 
analytical region (450 nm) is partially overlapped by the inherent absorption of ulvan that would 
unavoidably cover the small absorption peak of the RGD conjugate. 
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2.3.1.7.2. RGD mimetic (RGDm) as alternative to a peptide containing RGD sequence 
2.3.1.7.2.1. Preparation of RGDm/UMA-based hydrogels 
As discussed in the previous paragraph the direct conjugation of a peptide containing an RGD 
sequence on ulvan posed concerns during its analytical assessment. Alternative strategies were 
evaluated to provide ulvan scaffolds with bioactive species with a fast and reliable method. UV 
crosslinking was selected as a straightforward procedure to easily conjugate the bioactive molecules 
onto the polysaccharide during the preparation of the three dimensional scaffold. To this aim the 
bioactive species needed to be modified with UV radical polymerizable groups such as acryloyyl or 
methacryloyl moieties. The biological activity of RGD is reported to be mainly related to the 
presence of the guanidine side group deriving from arginine. The decarboxylation product of 
arginine, that is 4-aminobutyl guanidine or agmatine (Figure 12), could apparently mimic some of 
the biological properties of RGD90.  
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Figure 12. Structure of arginine and agmatine. 
 
Indeed, polyethylene glycol (PEG)-based hydrogels surface-modified with agmatine residues were 
reported to promote cell adhesion, in contrast with plain PEG-based hydrogels91. This finding 
prompted us to investigate the efficacy of introducing guanidine side groups in the ulvan-based 
hydrogels to improve cell adhesion and proliferation. To this purpose, an RGD mimetic (RGDm) 
containing a photocrosslinkable functionality (Figure 13) was prepared according to a rapid and 
simple procedure92 and conjugated to ulvan methacrylate (UMA) through UV exposure. The 
development and use of RGDm was yet reported in literature and demonstred to be effective in the 
proliferation of cells on the constituted macroporous hydrogels91. 
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Figure 13. Structure of the RGD mimetic (RGDm). 
The envisaged strategy relied on conjugating a molecule containing both an arginine-type side chain 
and a radical polymerizable group to ulvan in order to improve the biocompatibility of the 
polysaccharide in a fast and straight-forward manner. The synthesis of RGDm was easily performed 
through esterification reaction of itaconic anhydride with agmatine sulfate in basic conditions 
(Scheme 5)92. A prominent advantage of this approach relied on the use of cheaper materials with 
respect to those employed in the direct conjugation of RGD containing peptides. 
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Scheme 5. Synthesis of RGD mimetic. Itaconic anhydride / agmatine sulphate mol ratio = 3 / 1. 
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Hydrogels were prepared by UV photocrosslinking of an aqueous solution of UMA (5% w/v) 
containing a low amount of a citocompatible photoinitiator (IRGACURE® 2959; 2.5% w/v) and 
different amounts of a solution of RGDm (Scheme 6). The amounts of RGDm used were very low, 
ranging from 0.05 % (w/w % respect to ulvan) to 10% (w/w % respect to ulvan). 
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Scheme 6. Photopolymerization of UMA with RGDm. DS of UMA: 1-1.2; the solutions were exposed to UV light (λ 
= 365 nm) for 10-15 minutes. 
 
An excessive exposition to UV light (20 minutes) caused the shrinking of the scaffolds due to 
excessive crosslinking. Hydrogels displaying optimal textures and shapes were obtained by 
exposing the relevant solutions to UV for 10-15 minutes. 
 
2.3.1.7.2.2. Qualitative analysis of RGDm contents 
The introduction of RGDm into UMA hydrogels was confirmed qualitatively by the Sakaguchy 
assay (Paragraph 2.3.1.7.1.3). The assay was applied to hydrogels crosslinked with increasing 
amounts of RGDm in order to either confirm the presence of the RGDm or evidence a correlation 
between the color intensity and the different amounts of RGDm used. Before the analysis the 
scaffolds were repeatedly washed with phosphate buffer saline (PBS; pH = 7.4; 0.1 M), to remove 
the RGDm adsorbed and not covalently linked to the surface. All the hydrogels crosslinked with 
different amount RGDm displayed red discoloration on their surfaces indicating a successful 
covalent incorporation of the comonomer (Figure 14). 
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Figure 14. Sakaguchy assay carried out on ulvan-based hydrogels containing different amount of RGDm. Percentages 
are reported as weight ratio between RGDm and ulvan. Plain UMA hydrogel was used as blank. 
 
The absence of correlation between the intensity of discoloration and the content of RGDm in the 
hydrogels could be interpreted by considering the different porosity of the samples, which cause a 
different permeation of the reagents in the scaffolds. 
 
2.3.1.7.2.5. Biological evaluation 
In order to evaluate the biocompatibility of the hydrogels containing RGDm a cell viability assay 
was performed. The assay was carried out by using the 3T3/BALB-C Clone A31 mouse embryo 
fibroblast cell line. Cells were grown in Dulbecco's Modified Eagles Medium (DMEM), seeded at 
an appropriate density (1 x 105cells/mL) directly on the hydrogels and allowed to proliferate at 
37°C in humidified atmosphere containing 5% CO2 for 72 hours. WST-1 assay was performed to 
assess cell viability by incubating the cell-seeded hydrogels with WST-1 reagent diluted 1:10 for 4 
hours at 37°C and 5% CO2. Formazan production, obtained from the reduction of 3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide by metabolically active cells, was detected 
at 450 nm, with 620 nm as reference wavelength, by using a Biorad Microplate Reader. The 
obtained data highlighted a low cell viability of all prepared samples mostly not correlated with 
RGDm content (Figure 15). 
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RGDm solution (µl) 
Figure 15. WST-1 cell viability assay performed on Ulvan based hydrogels prepared with different amounts of a 
solution of RGDm (5 mg RGDm/1ml H2O). Percentages are reported as weight ratio between RGDm and ulvan. 
 
The hydrogels containing different RGDm amounts were also analyzed by Confocal Laser Scanning 
Microscopy, after they were seeded with balb/3T3 clone A31 mouse embryo fibroblasts and 
cultured for 72 hours in appropriated growing conditions (Figure 16). The images revealed the 
presence of clusters onto the surface of the scaffold generally arranged as cells aggregates. Cells 
were not found in the inner part of the hydrogels. A slightly greater number of cells were found on 
hydrogels containing higher RGDm content thus suggesting a major capability of the 
biofunctionalized hydrogel to allow cell adhesion. The recorded low cell viability was interpreted as 
caused by the release of toxic substances from the hydrogels deriving both from the 
photopolymerization of the hydrogels and the byproduct of the RGDm. Further investigations will 
be devoted to the analysis of samples submitted to intensive purification. 
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Figure 16. Confocal Laser Scanning Microscopy performed on Ulvan based hydrogels prepared with different 
amounts of a solution of RGDm (5 mg RGDm/1ml H2O). 
 
2.3.1.7.3. Photocopolymerization of ulvan methacrylate (UMA) with gelatin methacrylate 
(GelMA). 
2.3.1.7.3.1. Preparation of UMA/GelMA-based hydrogels 
The conjugation of bioactive macromolecules onto synthetic matrices, has been widely reported as a 
valid strategy to sustain cell viability and promote cellular function onto these substrates93,94. 
Proteins such as fibrin95, matrigel96, and collagen97 have been successfully reported in this kind of 
applications. Indeed protein-based materials have the advantage of mimicking many features of 
extracellular matrix and thus have the potential to direct the migration, growth and organization of 
cells during tissue regeneration and wound healing and have a prominent role in the stabilization of 
encapsulated and transplanted cells. Our interest was focused on gelatin, a natural polymer derived 
from collagen commonly used for pharmaceutical and medical applications because of its 
biodegradability and biocompatibility in physiological environments98,99. Despite the animal origin, 
gelatin displays lower antigenicity in respect to collagen due to the denaturation process. Gelatin is 
a material frequently employed for the preparation of hydrogel systems able to promote cell 
proliferation, migration and spreading both in two100 and three dimensions100-102. Our strategy was 
to functionalize gelatin with radical polymerizable groups and conjugate it to ulvan methacrylate 
(UMA) by means of UV photopolymerization. The presence of gelatin into ulvan hydrogels was 
envisaged to improve their biocompatibility and favor cell proliferation onto their surfaces. The 
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preparation of gelatine methacrylate (GelMA) was easily performed by amidation of gelatin with an 
excess of methacrylic anhydride according to a procedure reported in literature (Scheme 7)103. 
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Scheme 7. Synthesis of gelatine methacrylate. 
 
The successful introduction of methacrylate groups onto gelatin was confirmed by 1HNMR and IR 
analysis. The 1H-NMR spectra of gelatin and GelMA (Figure 17) resulted almost superimposable 
except for the two peaks at 5.3 and 5.6 ppm attributed to the two protons linked to the vinylidenic 
double bond (–C=CH2) and the peak at 1.8 ppm, correlated to the methyl groups of the methacrylate 
(CH3–C=CH2). 
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Figure 17. 1H-NMR spectra of gelatin and GelMA in deuterated water (D2O). 
 
The infrared spectra of pure gelatin and GelMA (Figure 18) exhibited the characteristic amide 
absorption bands at 1647 cm-1 and 1540 cm-1. The peak relative to the presence of methacryloyl 
group was absent in the spectrum of GelMA since the degree of substitution recorded by 1H-NMR 
analysis was low and the amide bond exhibited a large absorption in the investigated region. 
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Figure 18. IR analysis of gelatin and GelMA. 
 
The degree of substitution of methacryloyl groups onto gelatin resulted low due to the low content 
of reactive amine groups in the macromolecule (3-4%)39, mostly constituted by the lysine side chain 
and terminal amine groups. The degree of substitution was calculated by comparing the normalized 
intensity of the peak of olefinic protons of methacrylate (7.2 ppm) with the intensity of the arylic 
groups of phenylalanine present in gelatine (5.3 and 5.6 ppm). Typical DS% values obtained were 
in the range of 3-4 % thus indicating a completely functionalization of the reactive amine group of 
gelatine with methacryloyl groups. The substitution degree of methacyloy groups in respect to the 
entire macromolecule resulted of 3.7%. The UMA/GelMA-based hydrogels were prepared by the 
UV photopolymerization of aqueous solutions of UMA and GelMA, containing the citocompatible 
photoinitiator IRGACURE 2959®. Optimal times of exposure resulted 10 minutes (Scheme 8)q, 
since the scaffolds containing higher amount of gelatin resulted too much brittle if exposed to UV 
for longer times. 
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Scheme 8. Photocopolymerization of UMA with GelMA. DS of UMA: 1-1.2; DS% of GelMA: 3.7%. Exposure time 
(UV light, λ = 365 nm) = 10 minutes. 
 
2.3.1.7.3.2. Swelling degree measurement 
Swelling degree measurements (SD%) were carried out on UV photocrosslinked UMA/GelMA-
based hydrogels by using PBS (0.1 M; pH = 7.4) as  swelling medium. Data obtained are reported 
in Figure 19. The hydrogels containing higher amounts of UMA (50-100%) reached the equilibrium 
values at 14 days and they proved to be stable during the whole experiment. The hydrogels having 
composition UMA/GelMA = 25/75 usually lost their integrity after about 1 week in PBS. 
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Figure 19. Swelling degree of UMA/GelMA-based hydrogels in PBS (0.1 M; pH = 7.4). UMA/GelMA=25/75 
hydrogels disintegrated after about 200 hours in PBS. 
 
The SD% values at equilibrium were found to increase by increasing the amount of UMA into the 
hydrogels. The swelling behaviors of the hydrogels are commonly affected by their crosslinking 
degree and the hydrophilicity of the constituting materials. The higher density of methacrylate 
groups present in UMA should lead to the formation of more crosslinked network thus reducing the 
water uptake of the constituted hydrogels3,48. Indeed the higher SD% values observed for the 
hydrogels containing higher amount of UMA were determined by the extremely high hydrophilicity 
of the ulvan material. 
 
2.3.1.7.3.3. IR analysis 
The photocopolmerization of UMA and GelMA was confirmed by FT-IR analysis. The spectra of 
the hybrid hydrogels taken at different compositions (Figure 20) were found to well correlate with 
the spectra of the precursors according to the amount used for the hydrogel preparation. The most 
relevant peaks used for the macromolecular characterization were those found at 1542 cm-1 and   
1121 cm-1 related respectively to Amide II vibration and C-N stretching vibration of GelMA and the 
peak at 1644 cm-1 related to the C=O absorption band of uronic acid of UMA. 
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Figure 20. FT-IR spectra of UMA/GelMA based hydrogel  
 
2.3.1.7.3.4. SEM analysis 
The morphology of the hydrogels was characterized by SEM analysis (Figure 21). The analysis was 
performed onto the hydrogels containing different composition of UMA and GelMA. The hydrogels 
presented an interconnected, three-dimensional porous network structure with a degree of porosity 
that was higher for the scaffolds containing higher amount of GelMA. The lower degree of 
crosslinking of the hydrogels containing more GelMA could be partially the cause of their higher 
porosity. Moreover an increase of the fiber like structure was observed with higher amount of 
ulvan. That is in accordance with the reported tendency of ulvan to appear as elongated filaments104. 
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a) UMA 100%                                 b) UMA/GelMA = 75/25 
             
 c) UMA/GelMA = 50/50                d) UMA/GelMA = 25/75              e) GelMA 100% 
 
Figure 21. SEM analysis of UMA/GelMA-based hydrogels. The images refers to the surface of the samples. The 
magnification is 200 x. 
 
2.3.1.7.3.5. Rheological analysis 
Dynamic frequency sweep tests were performed on the UMA/GelMA-based hydrogels after they 
have been swollen in PBS (pH = 7,1; 0.1 M; for 7 days). The test was performed by submitting the 
samples to periodical shear stress with frequency in the range of 0.01-10 Hz in the linear visco-
elastic region (strain amplitude 0.1%).  The tests were performed on the scaffolds characterized by 
different UMA/GelMA weight ratio 100/0, 75/25, 50/50. The hydrogels containing higher amounts 
of GelMA (UMA/GelMA = 25/75 and 0/100) provided not reproducible data due their physical 
unsteadiness. The mechanical weakness of these materials is induced by their lower degree of 
crosslinking, higher porosity and inherent physical properties of gelatin. Hydrogels containing 
higher amount of ulvan provided reproducible data as evidenced in Figure 22. The results showed 
that G’ of all samples was greater than G” in the lower range of frequency (0.1-7 Hz) reflecting a 
more elastic, rather than a viscous behavior of all scaffolds. In the range of frequency between 7 
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and 10 Hz the values of G’’ tend to increase in particular for the scaffold UMA/GelMA = 50/50 
showing a more viscous behavior probably due to the irreversible deformation of the hydrogels. 
 
 
 
 
Figure 22. Elastic and viscous moduli versus frequency for UMA/GelMA hydrogels in the frequency sweep test (0.01-
10 Hz). 
 
Furthermore higher amount of UMA in the analyzed samples proved to increase their stiffness as 
confirmed by the higher G’ values recorded. This behavior was expected on the basis of the positive 
correlation between the degree of crosslinking of a polymeric network and its mechanical 
properties.  
 
 
2.3.1.7.3.6. Biological evaluation 
The biocompatibility of the UMA/GelMA hydrogels was evaluated through a cell viability assay 
carried out by using 3T3/BALB-C Clone A31 mouse embryo fibroblast cell line. Cells were grown 
in Dulbecco's Modified Eagles Medium (DMEM), seeded directly onto the hydrogels and allowed 
to proliferate at 37°C in humidified atmosphere containing 5% CO2 for 72 hours. The assay was 
performed by incubating cell-seeded hydrogels with WST-1 reagent diluted 1:10 for 2, 5 and 7 days 
at 37°C and 5% CO2. Formazan production was detected at 450 nm, with 620 nm as reference 
wavelength, using a Biorad Microplate Reader (Figure 23).  
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Figure 23. WST-1 cell proliferation assay performed on UMA/GelMA based hydrogels prepared with different ratio 
(w/w) of the components at 2, 5 and 7 days. 
 
The cell viability on the sample containing only gelatin resulted high, as expected from the data 
reported in literature105,106. However the scaffolds containing higher amount of UMA showed a very 
low cell viability thus confirming the previous results reported for the UMA-hydrogels containing 
the RGD mimetic. In light of obtained results the low cell viability could be correlated to the 
intrinsic nature of ulvan. It is reported that highly hydrophilic surfaces prevent the adsorption of 
proteins, or these molecules are bound very weakly107. Therefore, the highly hydrophilic nature of 
ulvan could limit the cellular adhesion that leads to a low cell viability. 
 
2.3.2. Preparation of hydrogels by ionic interaction between ulvan and chitosan 
 
The strategies envisaged to enhance the biocompatibility of ulvan-based hydrogels did not provided 
good results in term of cellular attachment and proliferation.  The hypothesis was that ulvan 
inherently inhibited cell viability because of its highly hydrophilic character. Thusm a further 
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approach was undertaken to decrease the hydrophylicity of ulvan without modifying its structure 
with toxic chemicals or heavily compromise its structure. The idea was to neutralize the anionic 
charges of ulvan, thus decreasing its hydrophilic character, by complexation with chitosan a natural 
polycation well known for its biocompatibility. The preparation of such complexes defined as 
polyelectrolyte complexes (PECs) leads to the formations of physically crosslinked network 
potentially suitable for biomedical applications108. The main advantage of using PECs relies on their 
straightforward preparation while avoiding the use of toxic compounds. Covalently crosslinked 
hydrogels commonly need the use of chemicals not suitable for biomedical applications. Indeed 
these agents could both compromise the integrity of the substances to be entrapped (e.g. proteins, 
cells) and reveal toxic towards the host organism. 
 
2.3.2.1. Preparation of ulvan/chitosan-based polyelectrolyte complexes (PECs) 
Polyelectrolyte complexes are generally prepared by mixing oppositely charged polyelectrolytes, 
which associate at certain pHs due to the formation of strong but reversible electrostatic links. 
These direct interactions between the polymeric chains lead to the formation of networks with non-
permanent structures. In general, these polymeric networks are well tolerated, biocompatible and 
are more sensitive to changes in environmental conditions109,110. The formation and stability of 
these polyelectrolyte complexes depend on many factors such as the degree of ionization of each 
oppositely charged polyelectrolytes, their charge density, the charge distribution over the polymeric 
chains, the concentration of the polyelectrolytes, their mixing ratio, their molecular weight, the 
nature of the ionic groups, as well as the temperature, ionic strength and pH of the reaction 
medium111-114. The cationic polymer, usually employed for the preparation of PECs is chitosan in 
virtue of its biocompatibility, biodegradability, high charge density and biological activities such as 
antimicrobial activity and low immunogenicity30-36.  The preparation of ulvan/chitosan PECs was 
straightforward and gave coherent hydrogels in a fast and reliable manner (Scheme 9)115.  
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Scheme 9. Preparation and mechanism of formation of ulvan/chitosan based PECs. 
 
The high rates of complexation recorded during the PECs preparations were induced by the highly 
charged nature of the two polymers at the operating pH. Chitosan is readily soluble at pH below 6.0 
due to the quaternization of the amine groups (pKa = 6.3)30. In these conditions the amine groups 
get protonated and become positively charged thus making chitosan a water-soluble cationic 
polyelectrolyte. As the pH increases above 6, the amine groups of chitosan are stable in neutral 
form thus losing their ability to form electrostatic bonds with the anionic charges. The soluble–
insoluble transition occurs at a pH value around the pKa of the amines. Ulvan is present in its salt 
form at almost every operating pH due to the presence of sulfate groups, which are known to be 
very strong acid groups (pKa ≈ 1). 
 
2.3.2.2. Swelling degree measurement 
Dried PECs were swollen in PBS solution (0.1 M; pH = 7.4) and weighted at regular time intervals 
after removal of excess surface liquid by blotting with a soft tissue. The SD% values were 
calculated according to equation (1) (Figure 24). Higher SD% values were observed in the case of 
PECs containing greater amount of chitosan despite ulvan was more hydrophilic. This finding could 
be interpreted considering a lost of ulvan material during the first times of immersion due to a not 
complete complexation of this hydrophilic polysaccharide by chitosan. At equilibrium the SD% of 
PECs prepared with higher chitosan content (ulvan/chitosan ratio = 40/60 and 20/80) resulted 
similar. A possible explanation could be given by the achievement of a stable PEC composition 
reached after all unbounded ulvan has been release in the medium. 
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Figure 24. Swelling degree of ulvan/chitosan based hydrogel. Dry hydrogels were swollen in PBS (pH 7.4; 0.1 M). 
The swelling degree (SD%) was calculated as: SD% = [(Ws – Wd)/ Wd] x 100 where Ws is the weight of the swollen 
sample and Wd the weight of the dry sample. 
 
The picture reported in Figure 25 shows the PECs textures and morphology after the swelling 
degree measurement. The scaffold containing higher content of ulvan (ulvan/chitosan = 70/30) 
showed an evident loss of material after the immersion in PBS for 2 weeks, thus confirming the data 
reported for SD% measurements. On the contrary, the hydrogels containing amounts of chitosan 
higher than 30% preserved their shapes, probably because their composition was similar to that 
needed for a complete neutralization of the two polyelectrolytes. 
 
 
                U/C =70/30               U/C =60/40                    U/C =40/60                   U/C =20/80   
Figure 25. Ulvan/chitosan-based PECs after swelling degree in PBS (0.1M; pH = 7.4) for 2 weeks. U/C refers to the 
weight ratio between ulvan and chitosan. 
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2.3.2.3. IR analysis 
Figure 26 shows the FT-IR spectra of the lyophilized PECs recorded before and after the swelling 
degree experiments compared to the spectra of the pristine components.  
 
 
a)  
 
b)  
Figure 26. FT-IR spectra:  (a) native PECs; (b) swollen PECs. The analysed samples were lyophilized before the 
analysis. Swelling degree conditions: PBS, pH = 7.4, 0.1 M for 14 days. Highlighted in red are reported the peaks 
relevant to the presence of ulvan in the PEC, and in blue the peaks relevant to the presence of chitosan. 
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The formation of electrostatic bonds between ulvan and chitosan was revealed by the shifts from 
1622 cm-1 to 1635 cm-1, of the peak of the carboxylic groups of ulvan, and from 1596 cm-1 to 1564 
cm-1, due to the protonation of the amine group of chitosan. The intensity of the peaks at 1596 cm-1 
and 847 cm-1 (related to bending vibration of carboxylic groups of ulvan) varied with the 
ulvan/chitosan ratio reflecting the different composition of the scaffolds. The spectra of the swollen 
PECs (Figure 26b) resulted similar and almost superimposable apart from their nominal 
composition indicating the achievement of an equilibrium composition after all unbond ulvan has 
been released in the medium. The equilibrium composition seemed to be enriched with chitosan as 
confirmed by the FT-IR analysis. 
 
2.3.2.4. SEM analysis 
SEM analysis of PECs was carried out before and after swelling experiments. They presented an 
interconnected three dimensional porous structure (Figure 27). Native PECs showed the presence of 
increasing fiber-like structures with higher amounts of ulvan, reflecting the same behaviour 
observed in the SEM analysis of UMA/Gelma-based hydrogels (Paragraph 2.3.1.7.3.4). The 
swollen PECs containing higher amount of ulvan revealed a less regular and more collapsed 
structure likely due to the release of unbound ulvan during the swelling experiment. 
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            a) Native ulvan/chitosan = 20/80       e) Swollen ulvan/chitosan = 20/80 
                     
           b) Native ulvan/chitosan = 40/60      f) Swollen ulvan/chitosan = 40/60  
                     
           c) Native ulvan/chitosan = 60/40       g) Swollen ulvan/chitosan = 60/40 
                      
          d) Native ulvan/chitosan = 70/30        h) Swollen ulvan/chitosan = 70/30 
 
 
Figure 27. SEM analysis of ulvan/chitosan PEC. The images refers to the section of the samples. The magnification is 
200 x. Swelling degree conditions: PBS, pH = 7.4, 0.1 M for 14 days. 
 
2.3.2.5. Rheological analysis 
Dynamic frequency sweep tests were performed on the ulvan/chitosan-based PECs after they were 
swollen in PBS (pH = 7,1; 0.1 M; for 14 days). The test was performed by submitting the samples 
to periodical shear stress with frequency in the range of 0.01-10 Hz in the linear visco-elastic region 
(strain amplitude 0.1%).  The tests were performed on the scaffolds characterized by different 
ulvan/chitosan weight ratio 60/40, 40/60, 20/80. PECs containing ulvan and chitosan in the weight 
ratio of 70/30 were not analyzed due to the irregular shape of the relevant scaffold (Figure 25). The 
results showed that G’ of all PECs was greater than G” within the frequency range analyzed (Figure 
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28) reflecting a more elastic, rather than a viscous, behavior. The PECs containing higher amount of 
chitosan displayed higher G’ values thus indicating a stiffer nature of these hydrogels compared to 
those enriched with ulvan. Although the IR analysis indicated a similar equilibrium composition of 
the analyzed samples, the different rheological behavior could be explained by considering the less 
regular and collapsed structure of the PECs containing more ulvan (Figure 27). Indeed the ulvan 
released during the swelling experiment acted as porogen thus creating irregular voids in the 
scaffold structure and irreversibly weakening its mechanical stability. 
 
 
Figure 28. Frequency sweep analysis (0.01-10 Hz) of ulvan/chitosan PECs. Ulvan /chitosan ratio (w/w): 
20/80, 40/60, 60/40. 
 
2.3.2.6. Biological evaluation 
In order to evaluate the biocompatibility of the ulvan/chitosan-based PECs, cell viability assay was 
carried out. Before analysis PECs were extensively washed with water to remove acetic acid, 
sterilized under UV light, for 30 minutes on each side and incubated in Dulbecco's Modified Eagles 
Medium (DMEM) at 37 °C and 5% CO2 for 24 hours prior to cell seeding. BALB/3T3 Clone A31 
mouse embryo fibroblasts were selected as appropriate cell line to assess the biocompatibility of the 
PECs. The cell viability was measured by Alamar-Blue® assay after 3, 7, 14 and 21 days from the 
beginning of the experiment (Figure 29). A good cell viability and proliferation were generally 
observed in all types of hydrogels whose values were found to increase during the culturing period. 
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The results indicated the full citocompatibility of the analyzed PECs and the absence of toxic 
compounds released by the samples. 
 
Figure 29. Alamar -Blue® assay for at 3, 7, 14 and 21 days for PECs with different ulvan/chitosan ratio. 
 
A live/dead assay was carried out on cells seeded PECs to confirm the preliminary results and 
provide some information on the morphology of the hosted cells (Figure 31 a). This analysis 
depends on the properties of live cells to convert the virtually nonfluorescent cell-permeant calcein 
AM to the intensely fluorescent calcein. Calcein is retained within live cells, producing an intense 
uniform green fluorescence in live cells. Ethidium homodimer-1 enters in the cells with damaged 
membranes and binds to nucleic acids thereby producing a bright red fluorescence in dead cells. 
Live/dead results were consistent with those obtained by using the Alamar-blue assay, revealing a 
remarkable number of viable cells present in the investigated samples. The images recorded during 
the assay revealed the formation of cell clusters in the U20C80 and U40C60 samples. The U60C40 
PECs seemed to better sustain cell adhesion and spreading as confirmed by the presence of fusiform 
structures in the relevant image. 
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a)                                             b) 
Figure 30. Confocal photomicrographs of ulvan/chitosan-based PECs showing  (a) viable (green) and non viable cells 
(red) obtained by live/dead assay (21 days); (b) cell morphology and viability (21 days) with cytoskeleton dyed (red) 
with phalloidin-Rhodamine B isithiocyanate and nuclei dyed (blue) with DAPI. 
 
Nuclei and cytoskeleton morphology of the cell seeded onto PECs were further investigated by 
Confocal Laser Scanning Microscopy at 21 days of culture (Figure 30 b) to have a deeper insight 
about the biocompatibility of the scaffolds. The images of the cytoskeleton (red coloured) and 
nuclei (blue coloration) confirmed that cells mostly tend to aggregate in the form of cluster on these 
materials and the scaffold U60C40 proved to better sustain their proliferation.  
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2.4. Conclusion 
Different types of ulvan-based hydrogels have been successfully prepared by chemical and physical 
means. UV photocrosslinking represented a fast and straightforward method for the preparation of 
scaffolds after proper functionalization of ulvan with radical sensitive groups. To this aim ulvan 
was successfully conjugated separately with acrylate and methacrylate groups. In order to enhance 
the biocompatibility of the hydrogels, the conjugation with molecules capable to enhance cell 
viability and proliferation was performed. To that purpose a pentapeptide GRGDS, a molecule 
mimicking the RGD sequence and gelatin functionalized with methacrylate groups were employed. 
However biological evaluation of the developed hydrogels highlighted a low cellular viability. The 
preparation of ulvan/chitosan PECs represented an advantageous strategy in virtue of its rapidity, 
simplicity and the possibility of using commercial reagents. Biological evaluation of PECs 
highlighted good cell viability until 21 days.  
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3. γ-Polyglutamate (γ-PGA), a biodegradable polymer from 
renewable resources for active packaging 
 
 
Abstract 
Over the last decades, the use of polymers as food packaging materials has increased enormously 
due to their advantages over other traditional materials. In particular a growing interest is devoted to 
the development of materials from biodegradable biopolymers, particularly those derived from 
renewable resources. Our interests was focused on poly-γ-glutamic acid (γ-PGA), a biocompatible 
and biodegradable polymer obtained by microbial fermentation. The main drawback for using plain 
γ-PGA in food packaging is represented by its high hydrophilicity due to the high content of 
carboxylic groups. Moisture and water represent the typical environment surrounding food 
packaging materials. To this aim such matrices need to be stable in those conditions. Our strategy 
aimed at reducing γ-PGA hydrophilicity by conjugating it with a hydrophobic polymer. 
Polycaprolactone (PCL) was selected as hydrophobic copolymer in virtue of its reported 
biocompatibility and biodegradability. Different synthetic strategies have been investigated to graft 
polycaprolactone onto the carboxyl group of γ-PGA. Most of the envisaged approaches revealed 
unsuccessful due to the low reactivity of the terminal groups of PCL. The direct conjugation of the 
two polymers catalyzed by the addition of p-toluensulfonic acid proved to be the most promising 
approach as evidenced by 1H-NMR analysis of the obtained product. 
 
 
3.1. Introduction 
For more than fifty years, polymeric materials deriving from petrol chemical resources have been 
the most practical and economical solution for packaging applications due to their low cost,  
excellent optical, mechanical, and barrier properties, heat sealability, and resistance against water 
and grease. Despite these advantages the packaging based on conventional synthetic materials led to 
serious environmental concerns due mostly to their non-biodegradability. In the last decade there 
has been a growing interest in the development of materials for food packaging deriving from 
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renewable and sustainable resources1. The exploitation of biodegradable packaging has the great 
potential of reducing drastically the concerns related to the disposal of the waste material1,2. Food 
packaging materials must meet strict requirements such as barrier (water and oxygen permeability), 
mechanical (resistance to stretching and rupture) and optical properties (opacity and color). Recent 
research focused on the development of active packaging materials that by interacting with the 
environment would preserve food from deterioration3-6. Active packaging is primarily designed to 
prolong shelf life, improve safety and/or enhance sensory properties in foods and beverages. 
Antimicrobial preservative releasers, antioxidant releasers, and flavoring or aroma emitters are 
examples of active packaging systems for preservation and shelf life extension of foods and 
beverages or improving their quality. Food packaging materials from natural origin, such as 
polysaccharides, proteins, lipids, has been yet investigated7-10. Our interest has been focused on 
poly-γ-glutamic acid (γ-PGA), an anionic, water-soluble biodegradable, biocompatible and edible 
homo-polyamide produced by microbial fermentation (Figure 1). 
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Figure 1. Chemical structure of γ-PGA. 
 
γ-PGA consists of repeating glutamic acid units linked to each other by amide bonds between α-
amino and γ-carboxylic acid functional groups. This biodegradable polymer was first isolated in 
1937 by autoclaving capsules of Bacillus anthracis11. Later, it was discovered that several other 
Bacillus species were capable of secreting the polymer into culture growth medium as well as 
nematocysts of the eukaryotic organism Hydra (Hydrozoa, Cnidaria)12,13. B. licheniformis14 and B. 
subtilis15,16 have been majorly used for fermentative production of PGA. The naturally produced 
polymers are characterized by molecular weight up to 1 million containing nearly equal amounts of 
D- and L-units17. The ratio of the two optical isomers can be partially regulated through 
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conventional biotechnologies. Indeed the production of γ-PGA displaying variable degree of 
stereoregularity have been yet reported18. In virtue of its biodegradability, edibility, and 
biocompatibility γ-PGA has been demonstrated a valid material for various applications such as 
drug delivery19,20, tissue engineering21, cosmetics22 and food industries23,24. In food industry γ-PGA 
has been employed for prevention of aging of starch-based bakery products, and as an ice cream 
stabilizer25 but it has not yet reported in food packaging. The biocompatibility and biodegradability 
of γ-PGA and the possibility to obtain this material from renewable resources prompted us to 
investigate the feasibility of using it in food packaging applications. The chemical versatility of this 
material provided by the huge number of carboxyl groups contained along its backbone allows for a 
multiple functionalization of the polymer comprising the introduction of active molecules.  
However the main drawback that would hamper the use of γ-PGA in food packaging applications is 
its hydrophilic nature, which limits its use in high moisture environments. In order to reduce its 
hydrophilicity, our approach was to conjugate γ-PGA with a hydrophobic, polymeric material. 
Polycaprolactone (PCL) was selected as hydrophobic component in virtue of its reported 
biocompatibility and biodegradability26. Furthermore, the wide use of PCL both in biomedical and 
in food packaging applications strengthened by its approval by food and drug administration 
(FDA)27 prompted us to select it as the most suitable candidate for conjugation with γ-PGA. 
 
 
3.2. Experimental part 
 
3.2.1. Materials 
γ-PGA (100 kDa) was kindly supplied by Nattobioscience, ε-caprolactone (ε-CL; Aldrich) was 
distilled over CaH2 under vacuum, 1-butanol (BuOH; Sigma-Aldrich) was distilled over K2CO3, 
carbonyldiimidazole (CDI; Sigma-Aldrich) was crystallized in distilled tetrahydrofuran (THF), THF 
was distilled  over metallic sodium and benzophenone, DMSO (Panreac) was distilled over CaH2 
under vacuum, pyridine (Sigma-Aldrich) was distilled over KOH, HCl 37% (Panreac), Sn(Oct)2 
(Aldrich), paratoluensulfonyl chloride (TsCl; Aldrich), Hexane (Sigma-Aldrich); dioxane (Analar 
Normapur), diethyl ether (Sigma Aldrich), methanol (Carlo Erba), dichloromethane (J. T. Backer), 
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1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide (EDC; Aldrich), paratoluensulfonic acid (TsOH; 
Sigma-Aldrich),  4-dimethylaminopyridine (DMAP; Sigma), were used as received.  
 
3.2.2. Methods 
IR analysis 
FT-IR spectra were recorded as KBr pellets (1/100 mg), in the range of 4000-400 cm-1 by using a 
Jasco FT-IR 410 spectrophotometer with a resolution of 4 cm-1. 
 
1H-NMR analysis 
1H-NMR spectra were recorded on a Varian Gemini 200 spectrometer using a Sparc 4 (Sun) 
console and VNMR 6.1B software. Spectra were recorded on 1-2% (w/v) solutions, in deuterated 
DMSO at 20 °C. 1H-NMR Spectra were recorded at 200 MHz. 
 
Gel Permeation Chromatography (GPC) 
GPC (Jasco PU-1580 liquid chromatography equipped with a Jasco 830RI refractive index detector 
and Perkin Elmer LC-75 UV-Vis detector, using a PLgel guard column and two PLgel Mesopore 
(30 cm, 10 mm) columns) was used to determine the molecular weight (Mw) and molecular weight 
distribution (ID) of the polymeric samples. Chloroform was introduced as eluent at 1 ml/min flow 
rate. The molecular weights of samples were calculated based on polystyrene standard samples with 
a known narrow molecular weight distribution. 
 
 
Preparation of γ-PGA(H) 
In a 100 ml flask containing an aqueous solution of γ-PGA in the salt form (γ-PGA(Na)) (5% w/v), 
concentrated HCl was added until pH = 2. The pH was controlled by litmus paper. The solution was 
stirred at room temperature for 1 h and left still overnight, after which a white solid precipitated. 
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The solid was filtered and repeatedly washed with dioxane and diethyl ether. The solvent was 
evaporated under vacuum furnishing a white solid. Yield: 66%. The product was stored at room 
temperature in desiccator over P2O5. 1H-NMR (200 MHz, deuterated DMSO) δ (ppm): 1.6-2.6 (m, 
4H, CH2), 4.2 (s, 1H, CH), 8.2 (s, 1H, NH). IR (cm-1): 1593 (COOH), 1737 (CO), 3295 (NH). 
 
Polymerization of ε-CL 
A solution of Sn(Oct)2 in hexane (20 µl; 0.5% w/w respect to ε-CL) was added in a 25 ml two 
necked dried round bottomed flask, under nitrogen atmosphere. Hexane was then removed under 
vacuum in order to dry Sn(Oct)2. Then ε-CL (5 ml; 45.12 mmol) and variable amounts of 1-butanol 
(ε-CL/BuOH mol ratio 438/1 or 32/1 ) were added and mixed to homogeneity. The reaction mixture 
was left stirring at 110 °C for 4 h. At the end, the mixture was cooled to room temperature, 
dissolved in THF, and then precipitated twice in methanol and once in water. The product was 
freeze drying under vacuum providing a white solid and was stored at room temperature in 
desiccator over P2O5. Yield: 70-72%. 1H-NMR (200 MHz, CDCl3) δ (ppm): 1.3-1.5 (m, 2H, CH2), 
1.6-1.8 (m, 4H, CH2), 2.3 (t, 2H, CH2C=O), 4.1 (t, 2H, OCH2). IR (cm-1): 1722 (C=O), 2865 (CH2), 
2943 (CH2). 
 
Grafting of PCL on γ-PGA(H) mediated by EDC and DMAP 
In a 25 ml dried shlenk tube a solution containing γ-PGA(H) (2.5% w/v) and EDC (1-1.5 equiv. 
respect to COOH groups) was prepared in DMSO at 40 °C, under nitrogen atmosphere. A solution 
containing PCL (15% w/v) and DMAP (0.06-1.1 equiv. respect to COOH groups) in DMSO was 
separately prepared in a 10 ml dried shlenk tube and added dropwise to the γ-PGA(H) containing 
mixture. The reaction mixture was stirred at 40 °C for 48 h after which it was precipited in water, 
thus obtaining a white solid. The crude product was subsequently filtered and freeze-dried under 
vacuum at -50 °C. Yield: 60%. 1H-NMR spectra showed no evidence of the desired product. 
 
Grafting of PCL on γ-PGA(H) mediated by CDI 
In a 25 ml dried shlenk tube a solution of CDI (0.3 equiv. respect to COOH groups) and  γ-PGA(H) 
(5% w/v) was prepared in DMSO (2 ml), at room temperature under nitrogen atmosphere. The 
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mixture was left stirring at 80 °C for 17 h to allow the activation of the carboxyl groups of γ-
PGA(H). Subsequently  PCL2200 (Mn = 2,200 Da, 0.11 equiv. respect to COOH groups) was added 
and the reaction mixture was stirred at 80 °C for further 24 h. The mixture was precipitated twice in 
CHCl3 (1/10 v/v). After filtration the solid was repeatedly washed with diethyl ether and then dried 
under vacuum, thus furnishing a brown solid. Yield: 57% . 1H-NMR spectra showed no evidence of 
the desired product. 
 
Grafting of PCL on γ-PGA(H) mediated by paratoluensulfonyl chloride (TsCl). 
In a 50 ml dried three necked round bottomed flask, a solution containing γ-PGA(H) (2% w/v) in 
DMSO was prepared at 50 °C under nitrogen atmosphere. A solution containing PCL2200 (10% w/v; 
0.1 equiv. of OH groups of PCL respect to COOH groups of γ-PGA(H)), TsCl (1 equiv. respect to 
COOH groups of γ-PGA(H)), pyridine ( 2 equiv. respect to COOH groups of γ-PGA(H)) was added 
dropwise to the solution of γ-PGA(H). The reaction mixture was stirred at 50 °C for 21 h. 0.3 equiv. 
respect to COOH groups. 
 
Direct esterification of PCL on γ-PGA(H) mediated by TsOH. 
In a dried 25 ml three necked round bottomed flask, γ-PGA(H) (3% w/v) and PCL2200 (6% w/v; 0.1 
equiv. of OH groups of PCL respect to COOH groups of γ-PGA(H))  were dissolved in DMSO  
under nitrogen atmosphere at 70 °C. Subsequently TsOH (0.04 equiv. respect to COOH groups of 
γ-PGA(H)) was added and the reaction mixture was stirred at 70 °C for 46 h. The reaction mixture 
was twice precipitated in water (1/10 v/v), centrifuged, washed with water and freeze-dried under 
vacuum at -50 °C, furnishing a white solid. Yield: 55%. The product was characterized by 1H-NMR 
in deuterated DMSO. 1H-NMR (200 MHz, deuterated DMSO) δ (ppm): 1.3-1.5 (m, 2H, CH2 PCL), 
1.5-1.7 (m, 4H, CH2 PCL), 1.8-2.2 (m, 2H, PGA), 2.2-2.4 (m, 2H PCL), 4.1 (t, 1H,OCH2 PCL), 4.2 
(s, 1H, CH PGA), 8.2 (s, 1H, NH PGA). IR (cm-1): 1593 (COOH of γ-PGA(H)), 2867 (CH2 of 
PCL), 2947 (CH2 of PCL), 3292 (NH of γ-PGA(H). 
  
ROP of ε-CL on γ-PGA(H). 
In a dried 100 ml two necked round bottomed flask equipped with a magnetic stirrer, γ-PGA(H) 
(100 mg) and ε-CL (6 ml) were mixed under nitrogen atmosphere. The reaction mixture was stirred 
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at 210 °C for 2.5 h. The mixture was precipitated in acetone (1/10 v/v). After filtration the solid was 
dried under vacuum, thus furnishing a brown solid. Yield: 50% . 1H-NMR spectra showed no 
evidence of the desired product. 
 
 
3.3. Results and discussion 
 
3.3.1. Preparation of precursors for the functionalization of γ-PGA. 
Poly (ε-caprolactone) (PCL) was selected as the most suitable candidate for the conjugation to γ-
PGA for food packaging applications in virtue of its hydrophobicity, biodegradability and 
biocompatibility28. Its unique mechanical and chemical properties have resulted in its extensive 
commercial development for biomedical and materials applications29-32. PCL with different 
molecular weights were synthesized by ring opening polymerization (ROP) of ε-CL catalyzed by 
Sn(Oct)2 (Scheme 1)33,34.  
BuOH / Sn(Oct)2
110°C / 4 h
Bu
O
C
O
CH2
CH2
CH2
CH2
CH2
OH
n
O
O
 
             ε-CL                                                                                                PCL 
Entry  ε-CL / BuOH  Yield    Mna      Mnb      Mwb         Mw/Mn 
  (mol/mol)   (%)   (Da)    (Da)    (Da) 
    1        438     70  13,400  50,300  63,900           1.27 
    2         32     72    2,200    6,900    7,900           1.14 
Scheme 1. Synthesis of polycaprolactone. a: determined by 1H-NMR, b: determined by gel permeation chromatograpy 
(GPC). 
The polymerizations were performed in bulk by using 1-butanol as initiator at 110 °C providing the 
desired products with good yields (about 70%) and narrow dispersion indexes. 1H-NMR spectra 
confirmed the successful synthesis of the polymers (Figure 2).  
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Figure 2. 1H-NMR spectrum of PCL in CDCl3. 
 
Two types of PCL were prepared in order to evaluate how its molecular weight would affect the 
reactivity of the polymer in the grafting reaction with γ-PGA(H) and the hydrophilicity of γ-
PGA(H) after conjugation. PCL having different molecular weights were obtained by varying the 
molar ratio between ε-CL and the initiator 1-butanol. The number average molecular weight (Mn)  
was determinated both by 1H-NMR and gel permeation chromatography (GPC). 1H-NMR analysis 
was essential for the determination of the absolute values of Mn whereas GPC was used for the 
calculation of the dispersion index. GPC analysis, sensible to the hydrodynamic volume, furnished 
relative measures compared with standard solutions of polystyrene. The strategy envisaged for the 
synthesis of the amphiphilic copolymer consisted in two steps: (1) previous acidification of the 
commercial γ-PGA(Na) in order to made it soluble in organic solvent where PCL is commonly 
soluble; (2) conjugation between the acidified γ-PGA (γ-PGA(H)) and the hydroxyl terminated 
PCL. γ-PGA(H) was obtained by precipitating γ-PGA(Na) from aqueous solutions in acidic 
conditions (pH ≈ 2; Scheme 2)33. 
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HCl(aq) (pH=2) / r.t.
CH
CH2
CH2
C
O
NH
COONa
n
CH
CH2
CH2
C
O
NH
COOH
n
 
         γ-PGA(Na)           γ-PGA(H) 
Scheme 2. Acidification of commercial γ-PGA(Na). 
 
The 1H-NMR spectrum of the product in deuterated DMSO was in accordance with that of γ-
PGA(H) reported in literature33,35 (Figure 3): the peaks between 1.6 and 2.6 ppm were attributed to 
the CH2 groups of γ-PGA(H) and the peaks at 4.2 and 8.2 ppm were assigned respectively to the 
CH2 proton adjacent to the carboxylic group and the hydrogen linked to the amidic nitrogen. 
 
 
Figure 3. 1H-NMR spectrum of γ-PGA(H) recorded in deuterated DMSO. 
 
The successful acidification of γ-PGA(Na) was confirmed by FT-IR analysis. The comparison of 
the spectrum reported in Figure 4 revealed the shift of the peak of the carboxylate group from the 
salt form at 1603 cm-1 to the protonated form at 1737 cm-1. 
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Figure 4. FT-IR spectra of γ-PGA(Na) and γ-PGA(H). 
 
Different procedures were attempted to graft hydroxyl terminated PCL onto the pendant carboxyl 
groups of γ-PGA(H). The carboxyl groups of the polyamide were previously protonated to enhance 
the solubility of the polymer in organic solvents where PCL is allowing it to react in homogeneous 
conditions. Indeed the bulky aliphatic chain surrounding the hydroxyl group of PCL would 
definitely reduce its reactivity especially in biphasic conditions. The first approach was to graft PCL 
onto γ-PGA(H) through the direct ROP of ε-CL using the carboxylic groups of the γ-PGA(H) as 
initiators. Very few examples of this procedure are reported and most of the results indicated the 
formation of oligomers36-38. The use of Sn(Oct)2 as catalyst was avoided since its activity is reported 
to be inhibited by the presence of carboxyl groups36. The procedure was rapid and straightforward 
because consisting only in mixing γ-PGA(H) with ε-CL (0.06 equiv. respect to the carboxylic 
groups) at 210 °C (Scheme 3)36 but it proved unsuccessful as confirmed by 1H-NMR analysis. 
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Scheme 3. Direct ROP of ε-CL on γ-PGA(H). 
 
 
3.3.2. Study of functionalization of γ-PGA with PCL. 
All the investigated approaches were aimed to activate the carboxyl groups of γ-PGA(H) before 
conjugation with hydroxyl terminated PCL. The first attempt was performed by using EDC and 
DMAP according to a procedure previously reported in literature33. The reaction was carried out 
according to different experimental conditions (see Entry 1-3, Table 1) but the 1H-NMR analysis 
revealed the absence of the envisaged product and the presence of exclusively unreacted γ-PGA(H). 
The use of PCL at lower molecular weight (Mn = 2,200) was also attempted in order to increase the 
concentration of hydroxyl groups into the reaction solution and facilitate the conjugation between 
the two polymers. γ-PGA(H) was previously left to react with EDC for 2 hours before the addition 
of PCL and DMAP to favor the activation of carboxyl groups (Table 1, Entry 4). However the 
analysis of the isolated product did not reveal the presence of the desired copolymer. 
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  Entry      PCL       PCL/γ-PGA    [EDC]/[COOH]    [DMAP]/[COOH]     Temperature           Time 
     Mn (Da)        (w/w)              (mol/mol)          (mol/mol)         (°C)  (h) 
     1     13,400    1/1       1.2/1   1/1           40  24 
     2     13,400    2/1       1.5/1   1/16           40  96 
     3     13,400    2/1       1.5/1   1/16           60  48 
     4a       2,200    3/1       1.2/1  0.8/1           40  48 
     5b       2,200    3/1       1.2/1  0.8/1           40  48a 
Table 1. Experimental conditions attempted for grafting of γ-PGA onto PCL. a) PCL and DMAP were added to the 
solution of PGA(H)/EDC after a) 2 hours of activation, b) 15 minutes of activation. 
 
The time of activation of γ-PGA(H) with EDC was also reduced (Table 1, Entry 5) to avoid possible 
side reactions such as the irreversible formation of N-acylurea (Scheme 4)39. The formation of N-
acylurea is typically encountered in the reaction of activation of carboxylic groups with 
carbodiimides and it led to the lost of reactivity of carboxyl groups. 
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Scheme 4. Mechanism the formation of N-acylurea and the substitution product mediated by EDC. 
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The 1H-NMR analysis of the recovered product did not provide the spectrum of the desired product. 
The unsuccessful grafting of PCL macromolecule onto γ-PGA(H) prompted us to investigate 
alternative strategies for activations of carboxyl groups of γ-PGA(H). The use of 
carbonyldiimidazole (CDI) (Table 2, Entry 1) was envisaged in virtue of its reported efficacy in the 
activation of carboxyl groups40 and the absence of formation of toxic compounds during its 
reactions41. Hydroxyl terminated PCL2200 was used in virtue of its low molecular weight and added 
to a solution of γ-PGA(H) previously activated with a large excess of CDI in DMSO at 80 °C. The 
1H-NMR analysis of the recovered product did not afforded the spectrum of the envisaged product. 
CH
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O
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PCL2200 / DMSO
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Entry        PCL/γ-PGA       activating agent [A]           [A]/[COOH]          Temperature          Time 
           (w/w)                                                       (mol/mol)                    (°C)           (h) 
  1  2/1           CDI   1/3          80            24 
  2  2/1          TsCl   1/1          50            21 
                                                      Pyridine   2/1 
Table 2. Experimental condition for grafting PCL onto γ-PGA(H) in presence of activating agents. 
 
The condition paratoluensulfonyl chloride (TsCl)/pyridine was also employed in the activation of 
the carboxylic groups of γ-PGA(H) towards the esterification of the hydroxyl groups of PCL (Table 
2, Entry 2)41. A stochiometric amount of TsCl with respect to the carboxylic groups was added in a 
solution of γ-PGA(H) at 50 °C. An excess of pyridine was needed in order to neutralize the acid 
formed during the reaction. The 1H-NMR analysis of the obtained product did not revealed the 
presence of the desired product. The desired product was obtained by the direct esterification of the 
two macromolecules catalyzed by the addition of p-toluensulfonic acid (TsOH) (Sheme 5)42. 
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Scheme 5. Direct esterification of PCL and γ-PGA catalyzed by TsOH. 
After purification, the 1H-NMR analysis of the obtained product revealed the presence of the 
desired copolymer (Figure 5). The peaks at 4.1 (OCH2), 2.2-2.4 (CH2), 1.3-1.5 (CH2) and 1.5-1.7 
(CH2)  ppm were assigned to the methylene protons of PCL. The peaks at 1.8-2.2 (CH2), 4.2 (CH) 
and 8.2 (NH) ppm indicated the presence of γ-PGA(H) in the copolymer. These data are in 
accordance with those reported by the literature33. 
 
Figure 5. 1H-NMR spectrum of γ-PGA-PCL recorded in deuterated DMSO. 
 
The FT-IR analysis of the product (Figure 6) revealed the peaks at 2947 and 2867 cm-1, relevant to 
the stretching vibration of CH2 of PCL, and the peaks at 3295 and 1593 cm-1, relevant respectively 
129 
 
to –NH and –COOH stretching of γ-PGA thus confirming the successful conjugation of PCL onto 
γ-PGA(H). 
 
 
Figure 6. FT-IR spectra of γ-PGA(H), PCL and γ-PGA-PCL. 
 
 
3.4. Conclusion 
The grafting functionalization of γ-PGA with a hydrophobic moiety was performed in order to 
reduce its hydrophilicity and made it a suitable material for food packaging. Poly (ε-caprolactone) 
(PCL) was employed in virtue of its reported hydrophobicity, biocompatibility and 
biodegradability. Several attempts to graft the hydroxyl terminated PCL onto the acidified γ-PGA 
were performed by using different activating agents. Only the direct esterification catalyzed by 
TsOH provided the desired product as confirmed by spectral analysis. The failure of most 
investigated grafting reactions could be ascribed to the low reactivity of the hydroxyl-terminated 
group of PCL inactivated by its bulky aliphatic chain. 
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